KR20210156587A - Organic light-emitting compound and organic electroluminescent device using the same - Google Patents
Organic light-emitting compound and organic electroluminescent device using the same Download PDFInfo
- Publication number
- KR20210156587A KR20210156587A KR1020200074329A KR20200074329A KR20210156587A KR 20210156587 A KR20210156587 A KR 20210156587A KR 1020200074329 A KR1020200074329 A KR 1020200074329A KR 20200074329 A KR20200074329 A KR 20200074329A KR 20210156587 A KR20210156587 A KR 20210156587A
- Authority
- KR
- South Korea
- Prior art keywords
- group
- formula
- chloro
- compound
- mmol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 193
- -1 diaryl phosphine Chemical compound 0.000 claims description 70
- 125000003118 aryl group Chemical group 0.000 claims description 44
- 125000000217 alkyl group Chemical group 0.000 claims description 22
- 125000004429 atom Chemical group 0.000 claims description 22
- 238000002347 injection Methods 0.000 claims description 21
- 239000007924 injection Substances 0.000 claims description 21
- 239000011368 organic material Substances 0.000 claims description 21
- 125000001072 heteroaryl group Chemical group 0.000 claims description 20
- 125000001424 substituent group Chemical group 0.000 claims description 17
- 125000003342 alkenyl group Chemical group 0.000 claims description 15
- 125000000304 alkynyl group Chemical group 0.000 claims description 15
- XYFCBTPGUUZFHI-UHFFFAOYSA-N Phosphine Natural products P XYFCBTPGUUZFHI-UHFFFAOYSA-N 0.000 claims description 14
- 230000005525 hole transport Effects 0.000 claims description 14
- ZOXJGFHDIHLPTG-UHFFFAOYSA-N Boron Chemical group [B] ZOXJGFHDIHLPTG-UHFFFAOYSA-N 0.000 claims description 13
- 125000003545 alkoxy group Chemical group 0.000 claims description 13
- 125000004104 aryloxy group Chemical group 0.000 claims description 13
- 125000000753 cycloalkyl group Chemical group 0.000 claims description 13
- 125000000592 heterocycloalkyl group Chemical group 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 13
- 125000005103 alkyl silyl group Chemical group 0.000 claims description 12
- 125000005104 aryl silyl group Chemical group 0.000 claims description 12
- YZCKVEUIGOORGS-OUBTZVSYSA-N Deuterium Chemical group [2H] YZCKVEUIGOORGS-OUBTZVSYSA-N 0.000 claims description 8
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 8
- 229910052805 deuterium Inorganic materials 0.000 claims description 8
- 229910052736 halogen Inorganic materials 0.000 claims description 8
- 150000002367 halogens Chemical group 0.000 claims description 8
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims description 8
- 125000001931 aliphatic group Chemical group 0.000 claims description 7
- 125000005264 aryl amine group Chemical group 0.000 claims description 7
- 229910000073 phosphorus hydride Inorganic materials 0.000 claims description 6
- 239000008280 blood Substances 0.000 claims description 5
- 210000004369 blood Anatomy 0.000 claims description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims description 5
- 150000002431 hydrogen Chemical group 0.000 claims description 5
- 239000001257 hydrogen Substances 0.000 claims description 5
- 150000004982 aromatic amines Chemical class 0.000 claims description 4
- 125000000732 arylene group Chemical group 0.000 claims description 3
- 125000005549 heteroarylene group Chemical group 0.000 claims description 3
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 125000006615 aromatic heterocyclic group Chemical group 0.000 claims description 2
- 125000005647 linker group Chemical group 0.000 claims description 2
- 239000000463 material Substances 0.000 abstract description 64
- 239000005416 organic matter Substances 0.000 abstract 1
- 239000010410 layer Substances 0.000 description 121
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 99
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 99
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 66
- 230000015572 biosynthetic process Effects 0.000 description 60
- 238000003786 synthesis reaction Methods 0.000 description 60
- 238000002360 preparation method Methods 0.000 description 38
- 239000002904 solvent Substances 0.000 description 36
- 239000012044 organic layer Substances 0.000 description 35
- 238000006243 chemical reaction Methods 0.000 description 33
- 238000004440 column chromatography Methods 0.000 description 33
- 238000000605 extraction Methods 0.000 description 33
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 33
- VTXIJSKJUMZHBW-UHFFFAOYSA-N 2-chloro-3,5,6-triphenylpyrazine Chemical compound C=1C=CC=CC=1C=1N=C(C=2C=CC=CC=2)C(Cl)=NC=1C1=CC=CC=C1 VTXIJSKJUMZHBW-UHFFFAOYSA-N 0.000 description 31
- MJDDVTZXYXHTRY-UHFFFAOYSA-N 4-chloro-2,6-diphenylpyrimidine Chemical compound N=1C(Cl)=CC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 MJDDVTZXYXHTRY-UHFFFAOYSA-N 0.000 description 31
- AOUMVBHLRFETBH-UHFFFAOYSA-N ClC1=NN2C(C(=CC(=C2)C2=CC=CC=C2)C2=CC=CC=C2)=N1 Chemical compound ClC1=NN2C(C(=CC(=C2)C2=CC=CC=C2)C2=CC=CC=C2)=N1 AOUMVBHLRFETBH-UHFFFAOYSA-N 0.000 description 31
- JKHCVYDYGWHIFJ-UHFFFAOYSA-N Clc1nc(nc(n1)-c1ccc(cc1)-c1ccccc1)-c1ccccc1 Chemical compound Clc1nc(nc(n1)-c1ccc(cc1)-c1ccccc1)-c1ccccc1 JKHCVYDYGWHIFJ-UHFFFAOYSA-N 0.000 description 31
- ZBMWEOMVQJYWAG-UHFFFAOYSA-N 2-chloro-4-phenyl-[1]benzothiolo[2,3-d]pyrimidine Chemical compound C1=2C=CC=CC=2SC2=C1C(C1=CC=CC=C1)=NC(=N2)Cl ZBMWEOMVQJYWAG-UHFFFAOYSA-N 0.000 description 30
- DDGPPAMADXTGTN-UHFFFAOYSA-N 2-chloro-4,6-diphenyl-1,3,5-triazine Chemical compound N=1C(Cl)=NC(C=2C=CC=CC=2)=NC=1C1=CC=CC=C1 DDGPPAMADXTGTN-UHFFFAOYSA-N 0.000 description 26
- 238000003461 Miyaura Borylation reaction Methods 0.000 description 24
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 24
- 238000001308 synthesis method Methods 0.000 description 24
- 239000000203 mixture Substances 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 16
- 125000006575 electron-withdrawing group Chemical group 0.000 description 12
- 238000010992 reflux Methods 0.000 description 11
- 125000004432 carbon atom Chemical group C* 0.000 description 10
- 238000005160 1H NMR spectroscopy Methods 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 9
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 239000002019 doping agent Substances 0.000 description 9
- 239000000758 substrate Substances 0.000 description 9
- TVIVIEFSHFOWTE-UHFFFAOYSA-K tri(quinolin-8-yloxy)alumane Chemical compound [Al+3].C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1.C1=CN=C2C([O-])=CC=CC2=C1 TVIVIEFSHFOWTE-UHFFFAOYSA-K 0.000 description 9
- KUAJNPBDAGOXEW-UHFFFAOYSA-N 2-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C2=CC=C(C3(CCCCC3)C3=C4C=CC(Cl)=C3)C4=C2)OC1(C)C KUAJNPBDAGOXEW-UHFFFAOYSA-N 0.000 description 8
- JWWMUTCXVNBWGP-UHFFFAOYSA-N 4-chloro-2-phenyl-6-(4-phenylphenyl)pyrimidine Chemical compound C1(=CC=C(C=C1)C1=NC(=NC(=C1)Cl)C1=CC=CC=C1)C1=CC=CC=C1 JWWMUTCXVNBWGP-UHFFFAOYSA-N 0.000 description 8
- AGRSQJIINRQSGT-UHFFFAOYSA-N 4-chloro-2-phenyl-[1]benzothiolo[3,2-d]pyrimidine Chemical compound ClC=1C2=C(N=C(N1)C1=CC=CC=C1)C1=C(S2)C=CC=C1 AGRSQJIINRQSGT-UHFFFAOYSA-N 0.000 description 7
- 125000003003 spiro group Chemical group 0.000 description 7
- MBHPOBSZPYEADG-UHFFFAOYSA-N 2-bromo-9,9-dimethylfluorene Chemical compound C1=C(Br)C=C2C(C)(C)C3=CC=CC=C3C2=C1 MBHPOBSZPYEADG-UHFFFAOYSA-N 0.000 description 6
- NGHPDQGNXFFIQH-UHFFFAOYSA-N 5-amino-3,4-dihydroxy-n-[1-(8-hydroxy-1-oxo-3,4-dihydroisochromen-3-yl)-3-methylbutyl]-2-methylheptanamide Chemical compound C1=CC(O)=C2C(=O)OC(C(CC(C)C)NC(=O)C(C)C(O)C(O)C(N)CC)CC2=C1 NGHPDQGNXFFIQH-UHFFFAOYSA-N 0.000 description 6
- XNBYZTWZUOOWLL-UHFFFAOYSA-N 7-bromo-9,9-dimethylfluorene-2-carbonitrile Chemical compound C1=C(C#N)C=C2C(C)(C)C3=CC(Br)=CC=C3C2=C1 XNBYZTWZUOOWLL-UHFFFAOYSA-N 0.000 description 6
- 239000012153 distilled water Substances 0.000 description 6
- NIHNNTQXNPWCJQ-UHFFFAOYSA-N fluorene Chemical compound C1=CC=C2CC3=CC=CC=C3C2=C1 NIHNNTQXNPWCJQ-UHFFFAOYSA-N 0.000 description 6
- 150000002894 organic compounds Chemical class 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PQASHNWAFFRRRF-UHFFFAOYSA-N 2-(6'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C2=CC=C(C3(CCCCC3)C(C=C3)=C4C=C3Cl)C4=C2)OC1(C)C PQASHNWAFFRRRF-UHFFFAOYSA-N 0.000 description 5
- ITXMBBWIWVOYFU-UHFFFAOYSA-N 2-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-2'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane Chemical compound CC1(C)OB(C(C=C2C34CCCCC3)=CC=C2C(C=C2)=C4C=C2Cl)OC1(C)C ITXMBBWIWVOYFU-UHFFFAOYSA-N 0.000 description 5
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 4
- 150000004945 aromatic hydrocarbons Chemical class 0.000 description 4
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 description 4
- TXCDCPKCNAJMEE-UHFFFAOYSA-N dibenzofuran Chemical compound C1=CC=C2C3=CC=CC=C3OC2=C1 TXCDCPKCNAJMEE-UHFFFAOYSA-N 0.000 description 4
- IYYZUPMFVPLQIF-UHFFFAOYSA-N dibenzothiophene Chemical compound C1=CC=C2C3=CC=CC=C3SC2=C1 IYYZUPMFVPLQIF-UHFFFAOYSA-N 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 239000011521 glass Substances 0.000 description 4
- AMGQUBHHOARCQH-UHFFFAOYSA-N indium;oxotin Chemical compound [In].[Sn]=O AMGQUBHHOARCQH-UHFFFAOYSA-N 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 229910052751 metal Inorganic materials 0.000 description 4
- 239000002184 metal Substances 0.000 description 4
- 239000010409 thin film Substances 0.000 description 4
- JLBXMPBCAYRQSZ-UHFFFAOYSA-N 2'-bromospiro[cyclohexane-1,9'-fluorene] Chemical compound C12=CC(Br)=CC=C2C2=CC=CC=C2C21CCCCC2 JLBXMPBCAYRQSZ-UHFFFAOYSA-N 0.000 description 3
- VQGHOUODWALEFC-UHFFFAOYSA-N 2-phenylpyridine Chemical compound C1=CC=CC=C1C1=CC=CC=N1 VQGHOUODWALEFC-UHFFFAOYSA-N 0.000 description 3
- HQLUJRJXLAKTAA-UHFFFAOYSA-N 4'-bromospiro[cyclohexane-1,9'-fluorene] Chemical compound BrC1=CC=CC2=C1C1=CC=CC=C1C21CCCCC1 HQLUJRJXLAKTAA-UHFFFAOYSA-N 0.000 description 3
- SXOUNESKHJIXNK-UHFFFAOYSA-N 4-bromo-9,9-dimethylfluorene Chemical compound C1=CC=C(Br)C2=C1C(C)(C)C1=CC=CC=C12 SXOUNESKHJIXNK-UHFFFAOYSA-N 0.000 description 3
- LJEIPQPDLNYWNH-UHFFFAOYSA-N 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile Chemical compound N#CC(C=C1)=CC(C2(CCCCC2)C2=CC=C3)=C1C2=C3Br LJEIPQPDLNYWNH-UHFFFAOYSA-N 0.000 description 3
- PVTOBFCQYGZWJW-UHFFFAOYSA-N 5-bromo-9,9-dimethylfluorene-2-carbonitrile Chemical compound CC(C)(C1=CC=C2)C(C=C(C=C3)C#N)=C3C1=C2Br PVTOBFCQYGZWJW-UHFFFAOYSA-N 0.000 description 3
- KCBWAFJCKVKYHO-UHFFFAOYSA-N 6-(4-cyclopropyl-6-methoxypyrimidin-5-yl)-1-[[4-[1-propan-2-yl-4-(trifluoromethyl)imidazol-2-yl]phenyl]methyl]pyrazolo[3,4-d]pyrimidine Chemical compound C1(CC1)C1=NC=NC(=C1C1=NC=C2C(=N1)N(N=C2)CC1=CC=C(C=C1)C=1N(C=C(N=1)C(F)(F)F)C(C)C)OC KCBWAFJCKVKYHO-UHFFFAOYSA-N 0.000 description 3
- XTEOJPUYZWEXFI-UHFFFAOYSA-N butyl n-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate Chemical compound S1C(CC(C)C)=CC(C=2C=CC(CN3C=NC=C3)=CC=2)=C1S(=O)(=O)NC(=O)OCCCC XTEOJPUYZWEXFI-UHFFFAOYSA-N 0.000 description 3
- 125000003983 fluorenyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3CC12)* 0.000 description 3
- 230000009477 glass transition Effects 0.000 description 3
- 125000005842 heteroatom Chemical group 0.000 description 3
- 238000004770 highest occupied molecular orbital Methods 0.000 description 3
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 3
- CKPOISPEUWPZBX-UHFFFAOYSA-N n,3-dimethylpentan-3-amine;hydron;chloride Chemical compound Cl.CCC(C)(CC)NC CKPOISPEUWPZBX-UHFFFAOYSA-N 0.000 description 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 3
- 239000000523 sample Substances 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- KOFLVDBWRHFSAB-UHFFFAOYSA-N 1,2,4,5-tetrahydro-1-(phenylmethyl)-5,9b(1',2')-benzeno-9bh-benz(g)indol-3(3ah)-one Chemical compound C1C(C=2C3=CC=CC=2)C2=CC=CC=C2C23C1C(=O)CN2CC1=CC=CC=C1 KOFLVDBWRHFSAB-UHFFFAOYSA-N 0.000 description 2
- CWJIEOBEXVYGIE-UHFFFAOYSA-N 2'-chloro-6'-(9,9-dimethylfluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] Chemical compound CC1(C)C(C=C(C=C2)C3=CC(C(C(C45CCCCC4)=C4)=CC=C4Cl)=C5C=C3)=C2C2=CC=CC=C12 CWJIEOBEXVYGIE-UHFFFAOYSA-N 0.000 description 2
- OQXIKTIYIXVGKE-UHFFFAOYSA-N 2'-chloro-7'-(9,9-dimethylfluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] Chemical compound CC1(C)C(C=C(C=C2)C(C=C3)=CC(C4(CCCCC4)C4=C5)=C3C4=CC=C5Cl)=C2C2=CC=CC=C12 OQXIKTIYIXVGKE-UHFFFAOYSA-N 0.000 description 2
- DWHAWNZRQVKQDI-UHFFFAOYSA-N 3'-chloro-6'-(9,9-dimethylfluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] Chemical compound CC1(C)C(C=C(C=C2)C3=CC(C4=CC(Cl)=CC=C4C45CCCCC4)=C5C=C3)=C2C2=CC=CC=C12 DWHAWNZRQVKQDI-UHFFFAOYSA-N 0.000 description 2
- LDGHZKXLSLASAN-UHFFFAOYSA-N 4-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)benzonitrile Chemical compound N#CC(C=C1)=CC=C1C1=CC=C(C2(CCCCC2)C2=C3C=CC(Cl)=C2)C3=C1 LDGHZKXLSLASAN-UHFFFAOYSA-N 0.000 description 2
- AWXGSYPUMWKTBR-UHFFFAOYSA-N 4-carbazol-9-yl-n,n-bis(4-carbazol-9-ylphenyl)aniline Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(N(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 AWXGSYPUMWKTBR-UHFFFAOYSA-N 0.000 description 2
- DIVZFUBWFAOMCW-UHFFFAOYSA-N 4-n-(3-methylphenyl)-1-n,1-n-bis[4-(n-(3-methylphenyl)anilino)phenyl]-4-n-phenylbenzene-1,4-diamine Chemical compound CC1=CC=CC(N(C=2C=CC=CC=2)C=2C=CC(=CC=2)N(C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)C=2C=CC(=CC=2)N(C=2C=CC=CC=2)C=2C=C(C)C=CC=2)=C1 DIVZFUBWFAOMCW-UHFFFAOYSA-N 0.000 description 2
- XCKUXMCDYQXDNS-UHFFFAOYSA-N 5-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)quinoline Chemical compound ClC(C=C1)=CC2=C1C1=CC(C3=C(C=CC=N4)C4=CC=C3)=CC=C1C21CCCCC1 XCKUXMCDYQXDNS-UHFFFAOYSA-N 0.000 description 2
- AEUIQEHJWFTMDM-UHFFFAOYSA-N 8-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)quinoline Chemical compound ClC(C=C1)=CC2=C1C1=CC(C3=C4N=CC=CC4=CC=C3)=CC=C1C21CCCCC1 AEUIQEHJWFTMDM-UHFFFAOYSA-N 0.000 description 2
- 101000837344 Homo sapiens T-cell leukemia translocation-altered gene protein Proteins 0.000 description 2
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 2
- GLUUGHFHXGJENI-UHFFFAOYSA-N Piperazine Chemical compound C1CNCCN1 GLUUGHFHXGJENI-UHFFFAOYSA-N 0.000 description 2
- KYQCOXFCLRTKLS-UHFFFAOYSA-N Pyrazine Chemical compound C1=CN=CC=N1 KYQCOXFCLRTKLS-UHFFFAOYSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 102100028692 T-cell leukemia translocation-altered gene protein Human genes 0.000 description 2
- YTPLMLYBLZKORZ-UHFFFAOYSA-N Thiophene Chemical compound C=1C=CSC=1 YTPLMLYBLZKORZ-UHFFFAOYSA-N 0.000 description 2
- 229910045601 alloy Inorganic materials 0.000 description 2
- 239000000956 alloy Substances 0.000 description 2
- 229910052782 aluminium Inorganic materials 0.000 description 2
- 150000001412 amines Chemical class 0.000 description 2
- MWPLVEDNUUSJAV-UHFFFAOYSA-N anthracene Chemical compound C1=CC=CC2=CC3=CC=CC=C3C=C21 MWPLVEDNUUSJAV-UHFFFAOYSA-N 0.000 description 2
- IOJUPLGTWVMSFF-UHFFFAOYSA-N benzothiazole Chemical compound C1=CC=C2SC=NC2=C1 IOJUPLGTWVMSFF-UHFFFAOYSA-N 0.000 description 2
- 239000011203 carbon fibre reinforced carbon Substances 0.000 description 2
- 239000010406 cathode material Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 230000009977 dual effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 150000002739 metals Chemical class 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- 239000007773 negative electrode material Substances 0.000 description 2
- 125000001181 organosilyl group Chemical group [SiH3]* 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- PSBAIJVSCTZDDB-UHFFFAOYSA-N phenyl acetylsalicylate Chemical compound CC(=O)OC1=CC=CC=C1C(=O)OC1=CC=CC=C1 PSBAIJVSCTZDDB-UHFFFAOYSA-N 0.000 description 2
- 125000003367 polycyclic group Chemical group 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000027756 respiratory electron transport chain Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 229910052717 sulfur Inorganic materials 0.000 description 2
- DDWBRNXDKNIQDY-UHFFFAOYSA-N thieno[2,3-d]pyrimidine Chemical compound N1=CN=C2SC=CC2=C1 DDWBRNXDKNIQDY-UHFFFAOYSA-N 0.000 description 2
- XOLBLPGZBRYERU-UHFFFAOYSA-N tin dioxide Chemical compound O=[Sn]=O XOLBLPGZBRYERU-UHFFFAOYSA-N 0.000 description 2
- 238000004506 ultrasonic cleaning Methods 0.000 description 2
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 2
- 239000011787 zinc oxide Substances 0.000 description 2
- VCGRFBXVSFAGGA-UHFFFAOYSA-N (1,1-dioxo-1,4-thiazinan-4-yl)-[6-[[3-(4-fluorophenyl)-5-methyl-1,2-oxazol-4-yl]methoxy]pyridin-3-yl]methanone Chemical compound CC=1ON=C(C=2C=CC(F)=CC=2)C=1COC(N=C1)=CC=C1C(=O)N1CCS(=O)(=O)CC1 VCGRFBXVSFAGGA-UHFFFAOYSA-N 0.000 description 1
- MAYZWDRUFKUGGP-VIFPVBQESA-N (3s)-1-[5-tert-butyl-3-[(1-methyltetrazol-5-yl)methyl]triazolo[4,5-d]pyrimidin-7-yl]pyrrolidin-3-ol Chemical compound CN1N=NN=C1CN1C2=NC(C(C)(C)C)=NC(N3C[C@@H](O)CC3)=C2N=N1 MAYZWDRUFKUGGP-VIFPVBQESA-N 0.000 description 1
- ZGYIXVSQHOKQRZ-COIATFDQSA-N (e)-n-[4-[3-chloro-4-(pyridin-2-ylmethoxy)anilino]-3-cyano-7-[(3s)-oxolan-3-yl]oxyquinolin-6-yl]-4-(dimethylamino)but-2-enamide Chemical compound N#CC1=CN=C2C=C(O[C@@H]3COCC3)C(NC(=O)/C=C/CN(C)C)=CC2=C1NC(C=C1Cl)=CC=C1OCC1=CC=CC=N1 ZGYIXVSQHOKQRZ-COIATFDQSA-N 0.000 description 1
- MOWXJLUYGFNTAL-DEOSSOPVSA-N (s)-[2-chloro-4-fluoro-5-(7-morpholin-4-ylquinazolin-4-yl)phenyl]-(6-methoxypyridazin-3-yl)methanol Chemical compound N1=NC(OC)=CC=C1[C@@H](O)C1=CC(C=2C3=CC=C(C=C3N=CN=2)N2CCOCC2)=C(F)C=C1Cl MOWXJLUYGFNTAL-DEOSSOPVSA-N 0.000 description 1
- JYEUMXHLPRZUAT-UHFFFAOYSA-N 1,2,3-triazine Chemical compound C1=CN=NN=C1 JYEUMXHLPRZUAT-UHFFFAOYSA-N 0.000 description 1
- CRXBTDWNHVBEIC-UHFFFAOYSA-N 1,2-dimethyl-9h-fluorene Chemical group C1=CC=C2CC3=C(C)C(C)=CC=C3C2=C1 CRXBTDWNHVBEIC-UHFFFAOYSA-N 0.000 description 1
- APWRZPQBPCAXFP-UHFFFAOYSA-N 1-(1-oxo-2H-isoquinolin-5-yl)-5-(trifluoromethyl)-N-[2-(trifluoromethyl)pyridin-4-yl]pyrazole-4-carboxamide Chemical compound O=C1NC=CC2=C(C=CC=C12)N1N=CC(=C1C(F)(F)F)C(=O)NC1=CC(=NC=C1)C(F)(F)F APWRZPQBPCAXFP-UHFFFAOYSA-N 0.000 description 1
- KRVWTVYQGIOXQE-UHFFFAOYSA-N 1-(2,6-diphenoxyphenoxy)naphthalene Chemical group C=1C=CC(OC=2C=CC=CC=2)=C(OC=2C3=CC=CC=C3C=CC=2)C=1OC1=CC=CC=C1 KRVWTVYQGIOXQE-UHFFFAOYSA-N 0.000 description 1
- ABDDQTDRAHXHOC-QMMMGPOBSA-N 1-[(7s)-5,7-dihydro-4h-thieno[2,3-c]pyran-7-yl]-n-methylmethanamine Chemical compound CNC[C@@H]1OCCC2=C1SC=C2 ABDDQTDRAHXHOC-QMMMGPOBSA-N 0.000 description 1
- MYQDTCYXRATQOK-UHFFFAOYSA-N 2,3,5-triphenyl-6-[7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-2'-yl]pyrazine Chemical compound CC1(C)OB(C(C=C2)=CC(C3(CCCCC3)C3=C4)=C2C3=CC=C4C2=C(C3=CC=CC=C3)N=C(C3=CC=CC=C3)C(C3=CC=CC=C3)=N2)OC1(C)C MYQDTCYXRATQOK-UHFFFAOYSA-N 0.000 description 1
- ZAECUYKAYHFZBW-UHFFFAOYSA-N 2,4-diphenyl-6-[6'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-3'-yl]-1,3,5-triazine Chemical compound CC1(C)OB(C2=CC(C3=CC(C4=NC(C5=CC=CC=C5)=NC(C5=CC=CC=C5)=N4)=CC=C3C34CCCCC3)=C4C=C2)OC1(C)C ZAECUYKAYHFZBW-UHFFFAOYSA-N 0.000 description 1
- 125000004974 2-butenyl group Chemical group C(C=CC)* 0.000 description 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 description 1
- QPLQADKPIINZCM-UHFFFAOYSA-N 2-phenyl-4-(4-phenylphenyl)-6-[7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-2'-yl]pyrimidine Chemical compound CC1(C)OB(C(C=C2)=CC(C3(CCCCC3)C3=C4)=C2C3=CC=C4C2=CC(C(C=C3)=CC=C3C3=CC=CC=C3)=NC(C3=CC=CC=C3)=N2)OC1(C)C QPLQADKPIINZCM-UHFFFAOYSA-N 0.000 description 1
- FAIIBAPVULBEEH-UHFFFAOYSA-N 2-phenyl-4-[7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-2'-yl]-[1]benzothiolo[3,2-d]pyrimidine Chemical compound CC1(C)OB(C(C=C2)=CC(C3(CCCCC3)C3=C4)=C2C3=CC=C4C2=NC(C3=CC=CC=C3)=NC3=C2SC2=C3C=CC=C2)OC1(C)C FAIIBAPVULBEEH-UHFFFAOYSA-N 0.000 description 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 description 1
- 125000001494 2-propynyl group Chemical group [H]C#CC([H])([H])* 0.000 description 1
- HCDMJFOHIXMBOV-UHFFFAOYSA-N 3-(2,6-difluoro-3,5-dimethoxyphenyl)-1-ethyl-8-(morpholin-4-ylmethyl)-4,7-dihydropyrrolo[4,5]pyrido[1,2-d]pyrimidin-2-one Chemical compound C=1C2=C3N(CC)C(=O)N(C=4C(=C(OC)C=C(OC)C=4F)F)CC3=CN=C2NC=1CN1CCOCC1 HCDMJFOHIXMBOV-UHFFFAOYSA-N 0.000 description 1
- BYHQTRFJOGIQAO-GOSISDBHSA-N 3-(4-bromophenyl)-8-[(2R)-2-hydroxypropyl]-1-[(3-methoxyphenyl)methyl]-1,3,8-triazaspiro[4.5]decan-2-one Chemical compound C[C@H](CN1CCC2(CC1)CN(C(=O)N2CC3=CC(=CC=C3)OC)C4=CC=C(C=C4)Br)O BYHQTRFJOGIQAO-GOSISDBHSA-N 0.000 description 1
- WNEODWDFDXWOLU-QHCPKHFHSA-N 3-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2s)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-7,7-dimethyl-1,2,6,8-tetrahydrocyclopenta[3,4]pyrrolo[3,5-b]pyrazin-4-one Chemical compound C([C@@H](N(CC1)C=2C=NC(NC=3C(N(C)C=C(C=3)C=3C(=C(N4C(C5=CC=6CC(C)(C)CC=6N5CC4)=O)N=CC=3)CO)=O)=CC=2)C)N1C1COC1 WNEODWDFDXWOLU-QHCPKHFHSA-N 0.000 description 1
- SRVXSISGYBMIHR-UHFFFAOYSA-N 3-[3-[3-(2-amino-2-oxoethyl)phenyl]-5-chlorophenyl]-3-(5-methyl-1,3-thiazol-2-yl)propanoic acid Chemical compound S1C(C)=CN=C1C(CC(O)=O)C1=CC(Cl)=CC(C=2C=C(CC(N)=O)C=CC=2)=C1 SRVXSISGYBMIHR-UHFFFAOYSA-N 0.000 description 1
- IDQSAFVVLDCEBJ-UHFFFAOYSA-N 3-ethyl-n-methylpentan-3-amine;hydron;chloride Chemical compound Cl.CCC(CC)(CC)NC IDQSAFVVLDCEBJ-UHFFFAOYSA-N 0.000 description 1
- PIAPHQWVHLCHQD-UHFFFAOYSA-N 4-[6'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-3'-yl]benzonitrile Chemical compound CC1(C)OB(C2=CC(C3=CC(C(C=C4)=CC=C4C#N)=CC=C3C34CCCCC3)=C4C=C2)OC1(C)C PIAPHQWVHLCHQD-UHFFFAOYSA-N 0.000 description 1
- CMDMPHBFEJHMDS-UHFFFAOYSA-N 4-[7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-3'-yl]benzonitrile Chemical compound CC1(C)OB(C(C=C2)=CC3=C2C2=CC(C(C=C4)=CC=C4C#N)=CC=C2C32CCCCC2)OC1(C)C CMDMPHBFEJHMDS-UHFFFAOYSA-N 0.000 description 1
- KVCQTKNUUQOELD-UHFFFAOYSA-N 4-amino-n-[1-(3-chloro-2-fluoroanilino)-6-methylisoquinolin-5-yl]thieno[3,2-d]pyrimidine-7-carboxamide Chemical compound N=1C=CC2=C(NC(=O)C=3C4=NC=NC(N)=C4SC=3)C(C)=CC=C2C=1NC1=CC=CC(Cl)=C1F KVCQTKNUUQOELD-UHFFFAOYSA-N 0.000 description 1
- HQSCPPCMBMFJJN-UHFFFAOYSA-N 4-bromobenzonitrile Chemical compound BrC1=CC=C(C#N)C=C1 HQSCPPCMBMFJJN-UHFFFAOYSA-N 0.000 description 1
- IRPVABHDSJVBNZ-RTHVDDQRSA-N 5-[1-(cyclopropylmethyl)-5-[(1R,5S)-3-(oxetan-3-yl)-3-azabicyclo[3.1.0]hexan-6-yl]pyrazol-3-yl]-3-(trifluoromethyl)pyridin-2-amine Chemical compound C1=C(C(F)(F)F)C(N)=NC=C1C1=NN(CC2CC2)C(C2[C@@H]3CN(C[C@@H]32)C2COC2)=C1 IRPVABHDSJVBNZ-RTHVDDQRSA-N 0.000 description 1
- CHODTZCXWXCALP-UHFFFAOYSA-N 5-bromoquinoline Chemical compound C1=CC=C2C(Br)=CC=CC2=N1 CHODTZCXWXCALP-UHFFFAOYSA-N 0.000 description 1
- MGSPPKVGGHMQAV-UHFFFAOYSA-N 6,8-diphenyl-2-[7'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluorene]-2'-yl]-[1,2,4]triazolo[1,5-a]pyridine Chemical compound CC1(C)OB(C(C=C2)=CC(C3(CCCCC3)C3=C4)=C2C3=CC=C4C2=NN(C=C(C=C3C4=CC=CC=C4)C4=CC=CC=C4)C3=N2)OC1(C)C MGSPPKVGGHMQAV-UHFFFAOYSA-N 0.000 description 1
- WYVMCLRTNDPVBW-UHFFFAOYSA-N 7-(6'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)-9,9-dimethylfluorene-2-carbonitrile Chemical compound CC(C)(C1=C2)C(C=C(C=C3)C#N)=C3C1=CC=C2C1=CC=C(C2(CCCCC2)C(C=C2)=C3C=C2Cl)C3=C1 WYVMCLRTNDPVBW-UHFFFAOYSA-N 0.000 description 1
- RSZGKIJBELWUJL-UHFFFAOYSA-N 7-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-2'-yl)-9,9-dimethylfluorene-2-carbonitrile Chemical compound CC(C)(C1=C2)C(C=C(C=C3)C#N)=C3C1=CC=C2C(C=C1C23CCCCC2)=CC=C1C(C=C1)=C3C=C1Cl RSZGKIJBELWUJL-UHFFFAOYSA-N 0.000 description 1
- MVYISXRWPVVKFT-UHFFFAOYSA-N 7-(7'-chlorospiro[cyclohexane-1,9'-fluorene]-3'-yl)-9,9-dimethylfluorene-2-carbonitrile Chemical compound CC(C)(C1=C2)C(C=C(C=C3)C#N)=C3C1=CC=C2C1=CC=C(C2(CCCCC2)C2=C3C=CC(Cl)=C2)C3=C1 MVYISXRWPVVKFT-UHFFFAOYSA-N 0.000 description 1
- CYJRNFFLTBEQSQ-UHFFFAOYSA-N 8-(3-methyl-1-benzothiophen-5-yl)-N-(4-methylsulfonylpyridin-3-yl)quinoxalin-6-amine Chemical compound CS(=O)(=O)C1=C(C=NC=C1)NC=1C=C2N=CC=NC2=C(C=1)C=1C=CC2=C(C(=CS2)C)C=1 CYJRNFFLTBEQSQ-UHFFFAOYSA-N 0.000 description 1
- VFUDMQLBKNMONU-UHFFFAOYSA-N 9-[4-(4-carbazol-9-ylphenyl)phenyl]carbazole Chemical compound C12=CC=CC=C2C2=CC=CC=C2N1C1=CC=C(C=2C=CC(=CC=2)N2C3=CC=CC=C3C3=CC=CC=C32)C=C1 VFUDMQLBKNMONU-UHFFFAOYSA-N 0.000 description 1
- QZZPOKVEMAMJEA-UHFFFAOYSA-N BrC1=C2N=CC=CC2CC=C1 Chemical compound BrC1=C2N=CC=CC2CC=C1 QZZPOKVEMAMJEA-UHFFFAOYSA-N 0.000 description 1
- ZVASFUVJRPUINZ-UHFFFAOYSA-N CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C(CC=C4)(C5=CC=C(C6(CCCCC6)C6=C7C=C(B8OC(C)(C)C(C)(C)O8)C=C6)C7=C5)C5=C4N=CC=C5)C=C2C32CCCCC2)OC1(C)C Chemical compound CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C(CC=C4)(C5=CC=C(C6(CCCCC6)C6=C7C=C(B8OC(C)(C)C(C)(C)O8)C=C6)C7=C5)C5=C4N=CC=C5)C=C2C32CCCCC2)OC1(C)C ZVASFUVJRPUINZ-UHFFFAOYSA-N 0.000 description 1
- DHTQXVKSLQCKAY-UHFFFAOYSA-N CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C(CC=C4)(C5=CC=C(C6(CCCCC6)C6=C7C=CC(B8OC(C)(C)C(C)(C)O8)=C6)C7=C5)C5=C4N=CC=C5)C=C2C32CCCCC2)OC1(C)C Chemical compound CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C(CC=C4)(C5=CC=C(C6(CCCCC6)C6=C7C=CC(B8OC(C)(C)C(C)(C)O8)=C6)C7=C5)C5=C4N=CC=C5)C=C2C32CCCCC2)OC1(C)C DHTQXVKSLQCKAY-UHFFFAOYSA-N 0.000 description 1
- RPGWKQWQQRFKTP-UHFFFAOYSA-N CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C4(C5=CC=C(C6(CCCCC6)C6=C7C=C(B8OC(C)(C)C(C)(C)O8)C=C6)C7=C5)C(N=CC=C5)=C5C=CC4)C=C2C32CCCCC2)OC1(C)C Chemical compound CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C4(C5=CC=C(C6(CCCCC6)C6=C7C=C(B8OC(C)(C)C(C)(C)O8)C=C6)C7=C5)C(N=CC=C5)=C5C=CC4)C=C2C32CCCCC2)OC1(C)C RPGWKQWQQRFKTP-UHFFFAOYSA-N 0.000 description 1
- IILNHHINZNXXMM-UHFFFAOYSA-N CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C4(C5=CC=C(C6(CCCCC6)C6=C7C=CC(B8OC(C)(C)C(C)(C)O8)=C6)C7=C5)C(N=CC=C5)=C5C=CC4)C=C2C32CCCCC2)OC1(C)C Chemical compound CC1(C)OB(C(C=C2)=CC3=C2C2=CC=C(C4(C5=CC=C(C6(CCCCC6)C6=C7C=CC(B8OC(C)(C)C(C)(C)O8)=C6)C7=C5)C(N=CC=C5)=C5C=CC4)C=C2C32CCCCC2)OC1(C)C IILNHHINZNXXMM-UHFFFAOYSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- YUXIBTJKHLUKBD-UHFFFAOYSA-N Dibutyl succinate Chemical compound CCCCOC(=O)CCC(=O)OCCCC YUXIBTJKHLUKBD-UHFFFAOYSA-N 0.000 description 1
- 229910052688 Gadolinium Inorganic materials 0.000 description 1
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- AYCPARAPKDAOEN-LJQANCHMSA-N N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methyl-4-thieno[3,2-d]pyrimidinyl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide Chemical compound C1([C@H](NC(=O)N2C(C=3NN=C(NC=4C=5SC=CC=5N=C(C)N=4)C=3C2)(C)C)CN(C)C)=CC=CC=C1 AYCPARAPKDAOEN-LJQANCHMSA-N 0.000 description 1
- IDRGFNPZDVBSSE-UHFFFAOYSA-N OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F Chemical compound OCCN1CCN(CC1)c1ccc(Nc2ncc3cccc(-c4cccc(NC(=O)C=C)c4)c3n2)c(F)c1F IDRGFNPZDVBSSE-UHFFFAOYSA-N 0.000 description 1
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 description 1
- CBENFWSGALASAD-UHFFFAOYSA-N Ozone Chemical compound [O-][O+]=O CBENFWSGALASAD-UHFFFAOYSA-N 0.000 description 1
- PCNDJXKNXGMECE-UHFFFAOYSA-N Phenazine Natural products C1=CC=CC2=NC3=CC=CC=C3N=C21 PCNDJXKNXGMECE-UHFFFAOYSA-N 0.000 description 1
- 229920001609 Poly(3,4-ethylenedioxythiophene) Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical compound [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- LXRZVMYMQHNYJB-UNXOBOICSA-N [(1R,2S,4R)-4-[[5-[4-[(1R)-7-chloro-1,2,3,4-tetrahydroisoquinolin-1-yl]-5-methylthiophene-2-carbonyl]pyrimidin-4-yl]amino]-2-hydroxycyclopentyl]methyl sulfamate Chemical compound CC1=C(C=C(S1)C(=O)C1=C(N[C@H]2C[C@H](O)[C@@H](COS(N)(=O)=O)C2)N=CN=C1)[C@@H]1NCCC2=C1C=C(Cl)C=C2 LXRZVMYMQHNYJB-UNXOBOICSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- CUJRVFIICFDLGR-UHFFFAOYSA-N acetylacetonate Chemical compound CC(=O)[CH-]C(C)=O CUJRVFIICFDLGR-UHFFFAOYSA-N 0.000 description 1
- ORILYTVJVMAKLC-UHFFFAOYSA-N adamantane Chemical compound C1C(C2)CC3CC1CC2C3 ORILYTVJVMAKLC-UHFFFAOYSA-N 0.000 description 1
- 229910001573 adamantine Inorganic materials 0.000 description 1
- 239000012790 adhesive layer Substances 0.000 description 1
- HSFWRNGVRCDJHI-UHFFFAOYSA-N alpha-acetylene Natural products C#C HSFWRNGVRCDJHI-UHFFFAOYSA-N 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 239000004411 aluminium Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001454 anthracenes Chemical class 0.000 description 1
- 125000005428 anthryl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C3C(*)=C([H])C([H])=C([H])C3=C([H])C2=C1[H] 0.000 description 1
- 125000005605 benzo group Chemical group 0.000 description 1
- UFVXQDWNSAGPHN-UHFFFAOYSA-K bis[(2-methylquinolin-8-yl)oxy]-(4-phenylphenoxy)alumane Chemical compound [Al+3].C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC=C([O-])C2=NC(C)=CC=C21.C1=CC([O-])=CC=C1C1=CC=CC=C1 UFVXQDWNSAGPHN-UHFFFAOYSA-K 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 125000000609 carbazolyl group Chemical group C1(=CC=CC=2C3=CC=CC=C3NC12)* 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000006229 carbon black Substances 0.000 description 1
- 229910052804 chromium Inorganic materials 0.000 description 1
- 239000011651 chromium Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 229920001940 conductive polymer Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 238000003618 dip coating Methods 0.000 description 1
- 238000005401 electroluminescence Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 125000002534 ethynyl group Chemical group [H]C#C* 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000002220 fluorenes Chemical group 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- UIWYJDYFSGRHKR-UHFFFAOYSA-N gadolinium atom Chemical compound [Gd] UIWYJDYFSGRHKR-UHFFFAOYSA-N 0.000 description 1
- 229910052733 gallium Inorganic materials 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 229910052737 gold Inorganic materials 0.000 description 1
- 239000010931 gold Substances 0.000 description 1
- 230000005283 ground state Effects 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- APFVFJFRJDLVQX-UHFFFAOYSA-N indium atom Chemical compound [In] APFVFJFRJDLVQX-UHFFFAOYSA-N 0.000 description 1
- 229910003437 indium oxide Inorganic materials 0.000 description 1
- PJXISJQVUVHSOJ-UHFFFAOYSA-N indium(iii) oxide Chemical compound [O-2].[O-2].[O-2].[In+3].[In+3] PJXISJQVUVHSOJ-UHFFFAOYSA-N 0.000 description 1
- 125000003406 indolizinyl group Chemical group C=1(C=CN2C=CC=CC12)* 0.000 description 1
- 238000007641 inkjet printing Methods 0.000 description 1
- 229910052741 iridium Inorganic materials 0.000 description 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000000555 isopropenyl group Chemical group [H]\C([H])=C(\*)C([H])([H])[H] 0.000 description 1
- ZLTPDFXIESTBQG-UHFFFAOYSA-N isothiazole Chemical compound C=1C=NSC=1 ZLTPDFXIESTBQG-UHFFFAOYSA-N 0.000 description 1
- CTAPFRYPJLPFDF-UHFFFAOYSA-N isoxazole Chemical compound C=1C=NOC=1 CTAPFRYPJLPFDF-UHFFFAOYSA-N 0.000 description 1
- 239000002346 layers by function Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000004020 luminiscence type Methods 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- GMBXBKNMMIWUED-UHFFFAOYSA-N n-(2,2,6,6-tetramethylpiperidin-4-yl)-3-[(2,2,6,6-tetramethylpiperidin-4-yl)amino]propanamide Chemical compound C1C(C)(C)NC(C)(C)CC1NCCC(=O)NC1CC(C)(C)NC(C)(C)C1 GMBXBKNMMIWUED-UHFFFAOYSA-N 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 125000002868 norbornyl group Chemical group C12(CCC(CC1)C2)* 0.000 description 1
- WCPAKWJPBJAGKN-UHFFFAOYSA-N oxadiazole Chemical compound C1=CON=N1 WCPAKWJPBJAGKN-UHFFFAOYSA-N 0.000 description 1
- GJVFBWCTGUSGDD-UHFFFAOYSA-L pentamethonium bromide Chemical compound [Br-].[Br-].C[N+](C)(C)CCCCC[N+](C)(C)C GJVFBWCTGUSGDD-UHFFFAOYSA-L 0.000 description 1
- 125000001147 pentyl group Chemical group C(CCCC)* 0.000 description 1
- 125000002080 perylenyl group Chemical group C1(=CC=C2C=CC=C3C4=CC=CC5=CC=CC(C1=C23)=C45)* 0.000 description 1
- CSHWQDPOILHKBI-UHFFFAOYSA-N peryrene Natural products C1=CC(C2=CC=CC=3C2=C2C=CC=3)=C3C2=CC=CC3=C1 CSHWQDPOILHKBI-UHFFFAOYSA-N 0.000 description 1
- 125000005561 phenanthryl group Chemical group 0.000 description 1
- 125000005328 phosphinyl group Chemical group [PH2](=O)* 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920000767 polyaniline Polymers 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000000561 purinyl group Chemical group N1=C(N=C2N=CNC2=C1)* 0.000 description 1
- 125000003373 pyrazinyl group Chemical group 0.000 description 1
- 125000002098 pyridazinyl group Chemical group 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 125000004076 pyridyl group Chemical group 0.000 description 1
- 125000000246 pyrimidin-2-yl group Chemical group [H]C1=NC(*)=NC([H])=C1[H] 0.000 description 1
- 125000000714 pyrimidinyl group Chemical group 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 125000005493 quinolyl group Chemical group 0.000 description 1
- 229930195734 saturated hydrocarbon Natural products 0.000 description 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- XIIOFHFUYBLOLW-UHFFFAOYSA-N selpercatinib Chemical compound OC(COC=1C=C(C=2N(C=1)N=CC=2C#N)C=1C=NC(=CC=1)N1CC2N(C(C1)C2)CC=1C=NC(=CC=1)OC)(C)C XIIOFHFUYBLOLW-UHFFFAOYSA-N 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052710 silicon Inorganic materials 0.000 description 1
- 239000010703 silicon Substances 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N silicon dioxide Inorganic materials O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 239000004332 silver Substances 0.000 description 1
- XGVXKJKTISMIOW-ZDUSSCGKSA-N simurosertib Chemical compound N1N=CC(C=2SC=3C(=O)NC(=NC=3C=2)[C@H]2N3CCC(CC3)C2)=C1C XGVXKJKTISMIOW-ZDUSSCGKSA-N 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- XOTREVBPKJHQEX-UHFFFAOYSA-M sodium;2-(3,3,6,6-tetramethyl-1,8-dioxo-9-phenyl-4,5,7,9-tetrahydro-2h-acridin-10-yl)acetate Chemical compound [Na+].C1C(C)(C)CC(=O)C2=C1N(CC([O-])=O)C(CC(C)(C)CC1=O)=C1C2C1=CC=CC=C1 XOTREVBPKJHQEX-UHFFFAOYSA-M 0.000 description 1
- 239000008279 sol Substances 0.000 description 1
- 238000004528 spin coating Methods 0.000 description 1
- 238000010345 tape casting Methods 0.000 description 1
- VLLMWSRANPNYQX-UHFFFAOYSA-N thiadiazole Chemical compound C1=CSN=N1.C1=CSN=N1 VLLMWSRANPNYQX-UHFFFAOYSA-N 0.000 description 1
- RBNBDIMXFJYDLQ-UHFFFAOYSA-N thieno[3,2-d]pyrimidine Chemical compound C1=NC=C2SC=CC2=N1 RBNBDIMXFJYDLQ-UHFFFAOYSA-N 0.000 description 1
- 229930192474 thiophene Natural products 0.000 description 1
- 229910052718 tin Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 125000004306 triazinyl group Chemical group 0.000 description 1
- 238000001771 vacuum deposition Methods 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- VWQVUPCCIRVNHF-UHFFFAOYSA-N yttrium atom Chemical compound [Y] VWQVUPCCIRVNHF-UHFFFAOYSA-N 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- YVTHLONGBIQYBO-UHFFFAOYSA-N zinc indium(3+) oxygen(2-) Chemical compound [O--].[Zn++].[In+3] YVTHLONGBIQYBO-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/24—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to three ring carbon atoms
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/26—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/10—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D241/12—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
-
- H01L51/0052—
-
- H01L51/0054—
-
- H01L51/0067—
-
- H01L51/0071—
-
- H01L51/5072—
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/14—Carrier transporting layers
- H10K50/16—Electron transporting layers
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/615—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene
- H10K85/622—Polycyclic condensed aromatic hydrocarbons, e.g. anthracene containing four rings, e.g. pyrene
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/654—Aromatic compounds comprising a hetero atom comprising only nitrogen as heteroatom
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K85/00—Organic materials used in the body or electrodes of devices covered by this subclass
- H10K85/60—Organic compounds having low molecular weight
- H10K85/649—Aromatic compounds comprising a hetero atom
- H10K85/657—Polycyclic condensed heteroaromatic hydrocarbons
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10K—ORGANIC ELECTRIC SOLID-STATE DEVICES
- H10K50/00—Organic light-emitting devices
- H10K50/10—OLEDs or polymer light-emitting diodes [PLED]
- H10K50/17—Carrier injection layers
Abstract
Description
본 발명은 신규한 유기 발광 화합물 및 이를 이용한 유기 전계 발광 소자에 관한 것으로, 보다 상세하게는 전자수송 능력이 우수한 화합물 및 이를 하나 이상의 유기물층에 포함함으로써 발광효율, 구동 전압, 수명 등의 특성이 향상된 유기 전계 발광 소자에 관한 것이다.The present invention relates to a novel organic light emitting compound and an organic electroluminescent device using the same, and more particularly, to a compound having excellent electron transport ability and an organic compound having improved characteristics such as luminous efficiency, driving voltage, and lifespan by including the compound in one or more organic material layers. It relates to an electroluminescent device.
1950년대 Bernanose의 유기 박막 발광 관측을 시점으로 1965년 안트라센 단결정을 이용한 청색 전기발광으로 이어진 유기 전계 발광 (electroluminescent, EL) 소자(이하, 간단히 '유기 EL 소자'로 칭함)에 대한 연구는 1987년 탕(Tang)에 의하여 정공층과 발광층의 기능층으로 나눈 적층구조의 유기 EL 소자가 제시되었다. 이후 고효율, 고수명의 유기 EL 소자를 만들기 위하여, 소자 내 각각의 특징적인 유기물 층을 도입하는 형태로 발전하여 왔으며, 이에 사용되는 특화된 물질의 개발로 이어졌다. A study on organic electroluminescent (EL) devices (hereinafter simply referred to as 'organic EL devices') that led to blue electroluminescence using anthracene single crystals in 1965, starting with Bernanose's observation of organic thin film emission in the 1950s, began in 1987. (Tang) presented an organic EL device having a stacked structure divided into a functional layer of a hole layer and a light emitting layer. Since then, in order to make a high-efficiency, long-life organic EL device, it has been developed in the form of introducing each characteristic organic material layer in the device, leading to the development of a specialized material used for this.
유기 전계 발광 소자는 두 전극 사이에 전압을 걸어 주면 양극에서는 정공이 주입되고, 음극에서는 전자가 유기물층으로 주입된다. 주입된 정공과 전자가 만났을 때 엑시톤(exciton)이 형성되며, 이 엑시톤이 바닥상태로 떨어질 때 빛이 나게 된다. 이때 유기물층으로 사용되는 물질은 그 기능에 따라, 발광 물질, 정공 주입 물질, 정공 수송 물질, 전자 수송 물질, 전자 주입 물질 등으로 분류될 수 있다. When a voltage is applied between the two electrodes of the organic electroluminescent device, holes are injected from the anode, and electrons are injected into the organic material layer from the cathode. When the injected holes and electrons meet, an exciton is formed, and when the exciton falls to the ground state, light is emitted. In this case, the material used as the organic material layer may be classified into a light emitting material, a hole injection material, a hole transport material, an electron transport material, an electron injection material, etc. according to their function.
유기 EL 소자의 발광층 형성재료는 발광색에 따라 청색, 녹색, 적색 발광 재료로 구분될 수 있다. 그밖에, 보다 나은 천연색을 구현하기 위한 발광재료로 노란색 및 주황색 발광재료도 사용된다. 또한, 색순도의 증가와 에너지 전이를 통한 발광 효율을 증가시키기 위하여, 발광 재료로서 호스트/도펀트 계를 사용할 수 있다. 도판트 물질은 유기 물질을 사용하는 형광 도판트와 Ir, Pt 등의 중원자(heavy atoms)가 포함된 금속 착체 화합물을 사용하는 인광 도판트로 나눌 수 있다. 이러한 인광 재료의 개발은 이론적으로 형광에 비해 4배까지의 발광 효율을 향상시킬 수 있어 인광 도판트 뿐만 아니라 인광 호스트 재료들에 대해 관심이 집중되고 있다. The material for forming the light emitting layer of the organic EL device may be classified into blue, green, and red light emitting materials according to the emission color. In addition, yellow and orange light emitting materials are also used as light emitting materials for realizing better natural colors. In addition, in order to increase color purity and increase luminous efficiency through energy transfer, a host/dopant system may be used as a light emitting material. The dopant material may be divided into a fluorescent dopant using an organic material and a phosphorescent dopant using a metal complex compound containing heavy atoms such as Ir and Pt. The development of such a phosphorescent material can theoretically improve luminous efficiency up to four times compared to fluorescence, and thus, attention is focused on phosphorescent host materials as well as phosphorescent dopants.
현재까지 정공 주입층, 정공 수송층. 정공 차단층, 전자 수송층으로는, 하기 화학식으로 표현된 NPB, BCP, Alq3 등이 널리 알려져 있고, 발광 재료는 안트라센 유도체들이 형광 도판트/호스트 재료로서 보고되고 있다. 특히 발광재료 중 효율 향상 측면에서 큰 장점을 가지고 있는 인광 재료로서는 Firpic, Ir(ppy)3, (acac)Ir(btp)2 등과 같은 Ir을 포함하는 금속 착체 화합물이 청색, 녹색, 적색 도판트 재료로 사용되고 있다. 현재까지는 CBP가 인광 호스트 재료로 우수한 특성을 나타내고 있다. Until now, hole injection layer, hole transport layer. As the hole blocking layer and the electron transporting layer, NPB, BCP, Alq 3, etc. represented by the following chemical formulas are widely known, and anthracene derivatives have been reported as fluorescent dopant/host materials as light emitting materials. In particular, among the light emitting materials, as a phosphorescent material having a great advantage in terms of efficiency improvement , a metal complex compound containing Ir such as Firpic, Ir(ppy) 3 , (acac)Ir(btp) 2 , etc. is a blue, green, and red dopant material. is being used as So far, CBP has shown excellent properties as a phosphorescent host material.
그러나 기존의 재료들은 발광 특성 측면에서는 유리한 면이 있으나, 유리전이온도가 낮고 열적 안정성이 매우 좋지 않아 유기 EL 소자에서의 수명 측면에서 만족할만한 수준이 되지 못하고 있다.However, although the existing materials have advantages in terms of luminescent properties, they are not satisfactory in terms of lifespan in organic EL devices due to their low glass transition temperature and very poor thermal stability.
본 발명은 특정 헤테로환 화합물을 유기 전계 발광 소자에 적용할 수 있으며, 상기 특정 헤테로환 화합물을 유기 전계 발광소자의 공통층인 전자수송층(ETL) 재료로 사용하여 저전압, 고효율 및 장수명 특성을 모두 우수한 신규 유기 화합물을 제공하는 것을 목적으로 한다.In the present invention, a specific heterocyclic compound can be applied to an organic electroluminescent device, and the specific heterocyclic compound is used as an electron transport layer (ETL) material, which is a common layer of an organic electroluminescent device. An object of the present invention is to provide a novel organic compound.
또한, 본 발명은 상기 신규 유기 화합물을 포함하여 낮은 구동 전압과 높은 발광 효율을 나타내며 수명이 향상되고 전자 주입 및 수송능이 개선된 전자 수송층용 재료, 정공 주입 및 수송능이 개선된 정공수송층 재료 및 이를 포함하는 유기 전계 발광 소자를 제공하는 것을 또 다른 목적으로 한다.In addition, the present invention includes a material for an electron transport layer with improved lifespan and improved electron injection and transport ability, a hole transport layer material with improved hole injection and transport ability, and a material for the hole transport layer including the novel organic compound, which exhibits low driving voltage and high luminous efficiency, and includes the same Another object of the present invention is to provide an organic electroluminescent device.
상기한 목적을 달성하기 위해, 본 발명은 하기 화학식 1로 표시되는 화합물을 제공한다.In order to achieve the above object, the present invention provides a compound represented by the following formula (1).
[화학식 1][Formula 1]
상기 화학식 1에서,In Formula 1,
L은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되며,L is a single bond, or is selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms,
n 은 0 내지 3의 정수이며,n is an integer from 0 to 3,
상기 A 및 B는 각각 독립적으로 하기 화학식 2 내지 화학식 4 중 어느 하나로 표시되는 치환기이며,A and B are each independently a substituent represented by any one of the following Chemical Formulas 2 to 4,
[화학식 2][Formula 2]
[화학식 3][Formula 3]
[화학식 4][Formula 4]
상기 화학식 2 내지 화학식 4에서,In Formulas 2 to 4,
*는 결합이 이루어지는 부분이고,* is the part where the bond is made,
복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, A로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며,A plurality of Xs are the same or different from each other, and each independently C (R) or N, but X represented by Formula 2 and Formula 3 represented by A is at least two or more N,
R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있고,R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms To 40 heterocycloalkyl group, C 6 ~ C 60 Aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 Alkyloxy group, C 6 ~ C 60 Aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ mono or diaryl phosphine of C 60 blood group and a C 6 ~ C is selected from the 60 group consisting of aryl amines, form a condensed ring of the group aliphatic, aromatic, aliphatic hetero, or aromatic heterocyclic group which are adjacent to each other, or to achieve a spiro bond there is,
상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other,
m 은 1 내지 3의 정수이며,m is an integer from 1 to 3,
Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있으며,When Ar1 is plural, the same or different from each other, and each independently is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, It is a substituted or unsubstituted heteroaryl group, and may form a condensed ring with adjacent X,
Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이다.Ar2 and Ar3 are the same as or different from each other, and each independently represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.
또한, 본 발명은 양극, 음극 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하고, 상기 1층 이상의 유기물 층에서 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자를 제공한다.In addition, the present invention includes an anode, a cathode, and one or more organic material layers interposed between the positive and negative electrodes, wherein at least one of the one or more organic layers includes a compound represented by Formula 1 above. A light emitting device is provided.
여기서, 상기 화학식 1로 표시되는 화합물을 포함하는 1층 이상의 유기물층 중 적어도 하나는 정공 주입층, 정공 수송층, 발광층, 전자 수송층, 전자수송 보조층 및 전자 주입층으로 이루어진 군으로부터 선택될 수 있으며, 전자 수송층, 전자수송 보조층 및/또는 발광층인 것이 바람직하다. 이때 상기 화학식 1로 표시되는 화합물은 전자 수송층 재료, 전자 수송 보조층 재료 및/또는 발광층 재료이다.Here, at least one of the one or more organic material layers including the compound represented by Formula 1 may be selected from the group consisting of a hole injection layer, a hole transport layer, a light emitting layer, an electron transport layer, an electron transport auxiliary layer, and an electron injection layer, It is preferably a transport layer, an electron transport auxiliary layer and/or a light emitting layer. In this case, the compound represented by Formula 1 is an electron transport layer material, an electron transport auxiliary layer material, and/or a light emitting layer material.
본 발명의 화합물은 발광 효율, 구동 전압, 수명 등이 우수하기 때문에 유기 전계 발광 소자의 유기물층 재료로 유용하게 적용될 수 있으며, 본 발명의 화합물을 유기물층에 포함하는 유기 전계 발광 소자는 발광 효율, 구동 전압, 수명, 효율 등의 측면이 크게 향상되어 풀 칼라 디스플레이 패널 등에 효과적으로 적용될 수 있다.Since the compound of the present invention has excellent luminous efficiency, driving voltage, lifespan, etc., it can be usefully applied as an organic material layer material of an organic electroluminescent device. , life, efficiency, etc. are greatly improved, so that it can be effectively applied to a full-color display panel.
도 1은 본 발명의 일 실시예에 따른 유기 전계 발광 소자의 단면도를 나타낸 것이다.
도 2는 본 발명의 일 실시예에 따른 유기 전계 발광 소자의 단면도를 나타낸 것이다.1 is a cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.
2 is a cross-sectional view of an organic electroluminescent device according to an embodiment of the present invention.
이하, 본 발명을 상세히 설명한다.Hereinafter, the present invention will be described in detail.
1. 유기화합물1. Organic compounds
본 발명은 발광 효율, 구동 전압, 수명 등이 우수한 신규 플루오렌계 화합물을 제공한다.The present invention provides a novel fluorene-based compound excellent in luminous efficiency, driving voltage, lifespan, and the like.
구체적으로, 본 발명에 따른 신규 유기 화합물은 플루오렌의 9번 위치에 지방족 고리기, 예컨대 시클로헥실기가 스피로(spiro) 형태로 치환된 것을 코어(core)로 채택하고, 상기 코어 구조의 페닐기에 전자 수송능이 뛰어난 전자끄는기(electron withdrawing group: EWG)가 결합되어 기본 골격을 이룬다.Specifically, in the novel organic compound according to the present invention, an aliphatic ring group, such as a cyclohexyl group, substituted in a spiro form at the 9th position of fluorene is adopted as a core, and a phenyl group of the core structure is adopted. An electron withdrawing group (EWG) with excellent electron transport ability is combined to form a basic skeleton.
이러한 구조의 화학식 1로 표시되는 화합물은, 플루오렌 9번 위치에 지방족 고리기가 형성됨에 따라, 기존에 알려진 디메틸 플루오렌 구조에 비해 전기화학적으로 안정하다. 또한, 전자이동속도를 향상시키기 위하여 강한 전자끌개능력(EWG)을 가진 작용기인 전자끄는기를 코어의 양측에 이중의 교차 형태(Cross type)로 도입함으로써 전자주입 및 전자수송에 더욱 적합한 물리화학적 성질을 가질 수 있게 된다.The compound represented by Formula 1 having such a structure is electrochemically stable compared to the conventionally known dimethyl fluorene structure as an aliphatic ring group is formed at the 9th position of fluorene. In addition, physicochemical properties more suitable for electron injection and electron transport by introducing an electron withdrawing group, a functional group with strong electron withdrawing capability (EWG), in a double cross type on both sides of the core to improve the electron transfer speed be able to have
상기 이중의 전자끄는기(Dual EWG)의 교차 형태는 수직 배향(Vertical orientation) 및 수평 배향(Horizontal orientation)의 형태의 입체구조로 도입될 수 있다. 본 발명의 화학식 1로 표시되는 화합물은 상기 수직 배향 형태로 인하여 뒤틀린(Twisted) 및 단단한(Rigid) 구조를 갖게 되며, 다음과 같은 이점이 있다. 높은 삼중항 에너지(Triplet energy)로부터 유도된 발광층에서 생성된 엑시톤(exciton)이 인접하는 전자 수송층 또는 정공 수송층으로 확산(이동)되는 것을 방지할 수 있다. 따라서 발광층 내에서 발광에 기여하는 엑시톤의 수가 증가되어 소자의 발광 효율이 개선될 수 있고, 소자의 내구성 및 안정성이 향상되어 소자의 수명이 효율적으로 증가될 수 있다. 또한, 높은 유리 전이온도(Tg) 및 열적 안정성 면에서 우수하며, 전자가 풍부한 지점(Electron-rich point)이 발생함에 따라 깊은 HOMO 레벨(Deep HOMO)을 유도한다.The cross shape of the dual electron withdrawing groups (Dual EWG) may be introduced as a three-dimensional structure in the form of a vertical orientation and a horizontal orientation. The compound represented by Formula 1 of the present invention has a twisted and rigid structure due to the vertical alignment, and has the following advantages. It is possible to prevent excitons generated in the light emitting layer derived from high triplet energy from diffusing (moving) into an adjacent electron transport layer or hole transport layer. Accordingly, the number of excitons contributing to light emission in the light emitting layer may be increased to improve luminous efficiency of the device, and durability and stability of the device may be improved to effectively increase the lifetime of the device. In addition, it is excellent in terms of high glass transition temperature (Tg) and thermal stability, and induces a deep HOMO level (Deep HOMO) as an electron-rich point occurs.
추가적으로, 본 발명의 화학식 1로 표시되는 화합물은 상기 수평 배향 형태로 인하여 이중쌍극자배열(dipole orientation) 구조를 갖게 되어, 전자수송능력(Fast Electron mobility)이 향상될 뿐만 아니라, 깊은 LUMO 레벨(Deep LUMO)을 유도하여 고전자 이동도(High electron mobility)를 향상시킬 수 있는 이점이 있다. 상기와 같은 효과로 인하여 개발된 재료들이 대부분 저전압 구동이 가능하여 이로 인한 수명이 개선되는 물리적 특징들을 나타낸다.Additionally, the compound represented by Formula 1 of the present invention has a dipole orientation structure due to the horizontal orientation, so that fast electron mobility is improved as well as a deep LUMO level (Deep LUMO). ) to induce high electron mobility (High electron mobility) has an advantage. Most of the materials developed due to the above effects exhibit low voltage driving, which results in improved lifespan.
따라서, 본 발명에 따른 신규 유기 화합물은 시클로헥실이 치환된 플로오렌을 사용하여 평면 형태를 유지함으로써 빠른 전자 이동 속도 및 고효율과 높은 수명, 낮은 구동전압에도 유리하며 열적으로 안정한 구조를 가질 수 있으며, 십자 형태의 입체 구조적으로써 HOMO 및 LUMO의 분리와 높은 삼중창 에너지를 갖는 이점이 있다.Therefore, the novel organic compound according to the present invention maintains a planar shape using fluorene substituted with cyclohexyl, which is advantageous for fast electron transfer speed, high efficiency, high lifespan, and low driving voltage, and can have a thermally stable structure, It has the advantage of having a high triple window energy and separation of HOMO and LUMO due to a cross-shaped three-dimensional structure.
아울러, 본 발명에서는 9번 위치에 지방족 고리기가 도입된 플루오렌 코어에, 정공(hole)과 전자(electron)에 대한 양쪽성의 물리화학적 성질을 가진 디벤조계 모이어티[예, dibenzofuran (DBF) 또는 dibenzothiophene (DBT)]를 적어도 하나 이상 포함할 수 있다. 이러한 디벤조계 모이어티와 강력한 electron-withdrawing group(EWG)인 질소 함유 방향족환(예, pyridine, pyrazine, triazine)과의 조합을 통해 우수한 발광효율 특성을 가진 그린 인광재료로서 적용할 수 있다. 또한, 저전압 구동이 가능하여 수명 상승 효과를 나타낼 수 있으며, 열적 안정성, 높은 유리전이온도 특성 및 균일한 모폴로지(morphology)를 가져 소자 특성이 우수하다.In addition, in the present invention, a dibenzo-based moiety [eg, dibenzofuran (DBF) or dibenzothiophene (DBT)]. It can be applied as a green phosphorescent material with excellent luminous efficiency through the combination of such a dibenzo-based moiety and a nitrogen-containing aromatic ring (eg, pyridine, pyrazine, triazine), which is a strong electron-withdrawing group (EWG). In addition, it is possible to drive at a low voltage, thereby exhibiting an effect of increasing the lifespan, and has excellent device characteristics due to thermal stability, high glass transition temperature characteristics, and uniform morphology.
전술한 바와 같이, 본 발명의 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 유기물층 재료, 바람직하게는 발광층 재료(청색, 녹색 및/또는 적색의 인광 호스트 재료), 전자 수송층/주입층 재료, 정공 수송층/주입층 재료, 발광 보조층 재료, 수명 개선층 재료로 적용할 경우, 유기 전계 발광 소자의 성능 및 수명 특성이 크게 향상될 수 있다. 이러한 유기 전계 발광 소자는 결과적으로 풀 칼라 유기 발광 패널의 성능을 극대화시킬 수 있다.As described above, the compound represented by Formula 1 of the present invention is an organic material layer material of an organic electroluminescent device, preferably a light emitting layer material (blue, green and/or red phosphorescent host material), electron transport layer/injection layer material, hole When applied as a transport layer/injection layer material, a light emitting auxiliary layer material, or a life improvement layer material, the performance and lifespan characteristics of the organic electroluminescent device can be greatly improved. As a result, such an organic electroluminescent device can maximize the performance of a full color organic light emitting panel.
이러한 화학식 1로 표시되는 화합물에서, 상기 L은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되며, n 은 0 내지 3의 정수이다.In the compound represented by Formula 1, L is a single bond, or is selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms, n is an integer of 0 to 3 to be.
상기 화학식 2 내지 화학식 4에서, *는 결합이 이루어지는 부분이고, 복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, A로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며, 상기 R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있다.In Formulas 2 to 4, * is a portion where a bond is formed, a plurality of Xs are the same or different from each other, and each independently C(R) or N, but X represented by Formulas 2 and 3 represented by A is At least two or more are N, wherein R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 of a cycloalkyl group, a heterocycloalkyl group having 3 to 40 nuclear atoms, a C 6 to C 60 aryl group, a heteroaryl group having 5 to 60 nuclear atoms, a C 1 to C 40 alkyloxy group, C 6 to C 60 of Aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 of an arylphosphine group, a C 6 ~ C 60 mono or diaryl phosphinyl group, and a C 6 ~ C 60 arylamine group, and a condensed ring of an aliphatic, aromatic, aliphatic hetero or aromatic hetero group with adjacent groups may form or form a spiro bond.
상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며, 상기 m 은 1 내지 3의 정수이며, 상기 Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있다.R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other, m is an integer from 1 to 3, and when Ar1 is plural, the same or different from each other, and each independently substituted or unsubstituted alkyl Or, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, a substituted or unsubstituted heteroaryl group, and may form a condensed ring with the adjacent X.
상기 Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이다.Ar2 and Ar3 are the same as or different from each other, and each independently represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.
구체적으로, 상기 화학식 2로 표시되는 화합물은 하기 화학식5 내지 화학식 10 중 어느 하나로 표시될 수 있다.Specifically, the compound represented by Formula 2 may be represented by any one of Formulas 5 to 10 below.
[화학식 5][Formula 5]
[화학식 6][Formula 6]
[화학식 7][Formula 7]
[화학식 8][Formula 8]
[화학식 9][Formula 9]
[화학식10][Formula 10]
상기 화학식 5 내지 화학식 10에서, *는 결합이 이루어지는 부분이고, Y는 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, In Formulas 5 to 10, * is a portion to which a bond is formed, Y is hydrogen, deuterium, halogen, cyano group, nitro group, C1-C40 alkyl group, C2-C4 0 alkenyl group, C 2 to C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 1 ~ C 40 alkyl Oxy group, C 6 ~ C 60 Aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 aryl phosphine is selected from the pingi, C 6 ~ C 60 mono or diaryl phosphine group P and the group consisting of C 6 ~ C 60 aryl group of an amine of,
X 및 Ar1은 각각 화학식 1에서 정의된 바와 같다X and Ar1 are each as defined in Formula 1
또한, 상기 화학식 3으로 표시되는 화합물은 하기 화학식 11로 표시될 수 있다.In addition, the compound represented by Formula 3 may be represented by Formula 11 below.
[화학식 11][Formula 11]
상기 화학식 11에서, *는 결합이 이루어지는 부분이고, X는 화학식 1에서 정의된 바와 같다.In Formula 11, * is a moiety to which a bond is formed, and X is as defined in Formula 1.
구체적으로, 상기 화학식 5는 하기 화학식 14 또는 화학식 15 중 어느 하나로 구체화될 수 있다.Specifically, Formula 5 may be embodied as any one of Formula 14 or Formula 15 below.
[화학식 14][Formula 14]
[화학식 15][Formula 15]
상기 화학식 14 또는 화학식 15에서, *는 결합이 이루어지는 부분이고, 상기 Ar1은 화학식 1에서 정의된 바와 같다.In Formula 14 or Formula 15, * is a portion where a bond is formed, and Ar1 is as defined in Formula 1.
구체적으로, 상기 화학식 6는 하기 화학식 16으로 구체화될 수 있다.Specifically, Formula 6 may be embodied as Formula 16 below.
[화학식 16][Formula 16]
상기 화학식 16에서, *는 결합이 이루어지는 부분이고, Ar1은 화학식 1에서 정의된 바와 같다.In Formula 16, * is a moiety to which a bond is formed, and Ar1 is as defined in Formula 1.
구체적으로, 상기 화학식 4는 하기 화학식 17로 구체화될 수 있다.Specifically, Formula 4 may be embodied as Formula 17 below.
[화학식 17][Formula 17]
상기 화학식 17에서, *는 결합이 이루어지는 부분이다.In Formula 17, * is a moiety to which a bond is formed.
상기 L은 단일결합이거나, 하기 L-1 내지 L-3 중에서 선택되는 링커일 수 있다. The L may be a single bond or a linker selected from the following L-1 to L-3.
상기 L-1 내지 L-3에서, *는 결합이 이루어지는 부분이다.In L-1 to L-3, * is a portion where a bond is formed.
이상에서 설명한 본 발명의 일례에 따른 화학식 1로 표시되는 화합물은 하기 예시된 화합물로 이루어진 군에서 선택되는 어느 하나로 표시되는 화합물로 보다 구체화될 수 있다. 그러나 본 발명의 화학식 1로 표시되는 화합물이 하기 예시된 것들에 의해 한정되는 것은 아니다.The compound represented by Formula 1 according to an example of the present invention described above may be further specified as a compound represented by any one selected from the group consisting of the compounds exemplified below. However, the compound represented by Formula 1 of the present invention is not limited by those exemplified below.
본 발명에서 "알킬"은 탄소수 1 내지 40의 직쇄 또는 측쇄의 포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 메틸, 에틸, 프로필, 이소부틸, sec-부틸, 펜틸, iso-아밀, 헥실 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyl" refers to a monovalent substituent derived from a linear or branched saturated hydrocarbon having 1 to 40 carbon atoms. Examples thereof include, but are not limited to, methyl, ethyl, propyl, isobutyl, sec-butyl, pentyl, iso-amyl, hexyl, and the like.
본 발명에서 "알케닐(alkenyl)"은 탄소-탄소 이중 결합을 1개 이상 가진탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 비닐(vinyl), 알릴(allyl), 이소프로펜일(isopropenyl), 2-부텐일(2-butenyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, “alkenyl” refers to a monovalent substituent derived from a linear or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having one or more carbon-carbon double bonds. Examples thereof include, but are not limited to, vinyl, allyl, isopropenyl, 2-butenyl, and the like.
본 발명에서 "알키닐(alkynyl)"은 탄소-탄소 삼중 결합을 1개 이상 가진탄소수 2 내지 40의 직쇄 또는 측쇄의 불포화 탄화수소에서 유래되는 1가의 치환기를 의미한다. 이의 예로는 에티닐(ethynyl), 2-프로파닐(2-propynyl) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkynyl" refers to a monovalent substituent derived from a straight or branched unsaturated hydrocarbon having 2 to 40 carbon atoms and having one or more carbon-carbon triple bonds. Examples thereof include, but are not limited to, ethynyl, 2-propynyl, and the like.
본 발명에서 "아릴"은 단독 고리 또는 2이상의 고리가 조합된 탄소수 6 내지 40의 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있다. 이러한 아릴의 예로는 페닐, 나프틸, 페난트릴, 안트릴 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryl" refers to a monovalent substituent derived from an aromatic hydrocarbon having 6 to 40 carbon atoms in which a single ring or two or more rings are combined. In addition, two or more rings may be simply attached to each other (pendant) or condensed form may be included. Examples of such aryl include, but are not limited to, phenyl, naphthyl, phenanthryl, anthryl, and the like.
본 발명에서 "헤테로아릴"은 핵원자수 5 내지 40의 모노헤테로사이클릭 또는 폴리헤테로사이클릭 방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이때, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로원자로 치환된다. 또한, 2 이상의 고리가 서로 단순 부착(pendant)되거나 축합된 형태도 포함될 수 있고, 나아가 아릴기와의 축합된 형태도 포함될 수 있다. 이러한 헤테로아릴의 예로는 피리딜, 피라지닐, 피리미디닐, 피리다지닐, 트리아지닐과 같은 6-원 모노사이클릭 고리, 페녹사티에닐(phenoxathienyl), 인돌리지닐(indolizinyl), 인돌릴(indolyl), 퓨리닐(purinyl), 퀴놀릴(quinolyl), 벤조티아졸(benzothiazole), 카바졸릴(carbazolyl)과 같은 폴리사이클릭 고리 및 2-퓨라닐, N-이미다졸릴, 2-이속사졸릴, 2-피리디닐, 2-피리미디닐 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heteroaryl" refers to a monovalent substituent derived from a monoheterocyclic or polyheterocyclic aromatic hydrocarbon having 5 to 40 nuclear atoms. In this case, one or more carbons in the ring, preferably 1 to 3 carbons, are substituted with a heteroatom such as N, O, S or Se. In addition, a form in which two or more rings are simply attached to each other or condensed may be included, and further, a form condensed with an aryl group may be included. Examples of such heteroaryl include 6-membered monocyclic rings such as pyridyl, pyrazinyl, pyrimidinyl, pyridazinyl, triazinyl, phenoxathienyl, indolizinyl, indolyl ( polycyclic rings such as indolyl), purinyl, quinolyl, benzothiazole, and carbazolyl, and 2-furanyl, N-imidazolyl, 2-isoxazolyl , 2-pyridinyl, 2-pyrimidinyl, and the like, but is not limited thereto.
본 발명에서 "아릴옥시"는 RO-로 표시되는 1가의 치환기로, 상기 R은 탄소수 5 내지 40의 아릴을 의미한다. 이러한 아릴옥시의 예로는 페닐옥시, 나프틸옥시, 디페닐옥시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "aryloxy" is a monovalent substituent represented by RO-, wherein R means aryl having 5 to 40 carbon atoms. Examples of such aryloxy include, but are not limited to, phenyloxy, naphthyloxy, diphenyloxy, and the like.
본 발명에서 "알킬옥시"는 R'O-로 표시되는 1가의 치환기로, 상기 R'는 탄소수 1 내지 40의 알킬을 의미하며, 직쇄(linear), 측쇄(branched) 또는 사이클릭(cyclic) 구조를 포함할 수 있다. 알킬옥시의 예로는 메톡시, 에톡시, n-프로폭시, 1-프로폭시, t-부톡시, n-부톡시, 펜톡시 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "alkyloxy" is a monovalent substituent represented by R'O-, wherein R' means an alkyl having 1 to 40 carbon atoms, and has a linear, branched or cyclic structure. may include Examples of alkyloxy include, but are not limited to, methoxy, ethoxy, n-propoxy, 1-propoxy, t-butoxy, n-butoxy, pentoxy, and the like.
본 발명에서 "아릴아민"은 탄소수 6 내지 40의 아릴로 치환된 아민을 의미한다.In the present invention, "arylamine" refers to an amine substituted with an aryl having 6 to 40 carbon atoms.
본 발명에서 "시클로알킬"은 탄소수 3 내지 40의 모노사이클릭 또는 폴리사이클릭 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미한다. 이러한 사이클로알킬의 예로는 사이클로프로필, 사이클로펜틸, 사이클로헥실, 노르보닐(norbornyl), 아다만틴(adamantine) 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "cycloalkyl" means a monovalent substituent derived from a monocyclic or polycyclic non-aromatic hydrocarbon having 3 to 40 carbon atoms. Examples of such cycloalkyl include, but are not limited to, cyclopropyl, cyclopentyl, cyclohexyl, norbornyl, adamantine, and the like.
본 발명에서 "헤테로시클로알킬"은 핵원자수 3 내지 40의 비-방향족 탄화수소로부터 유래된 1가의 치환기를 의미하며, 고리 중 하나 이상의 탄소, 바람직하게는 1 내지 3개의 탄소가 N, O, S 또는 Se와 같은 헤테로 원자로 치환된다. 이러한 헤테로시클로알킬의 예로는 모르폴린, 피페라진 등을 들 수 있으나, 이에 한정되지는 않는다.In the present invention, "heterocycloalkyl" means a monovalent substituent derived from a non-aromatic hydrocarbon having 3 to 40 nuclear atoms, and at least one carbon in the ring, preferably 1 to 3 carbons, is N, O, S or a hetero atom such as Se. Examples of such heterocycloalkyl include, but are not limited to, morpholine and piperazine.
본 발명에서 "알킬실릴"은 탄소수 1 내지 40의 알킬로 치환된 실릴이고, "아릴실릴"은 탄소수 5 내지 40의 아릴로 치환된 실릴을 의미한다.In the present invention, "alkylsilyl" refers to silyl substituted with alkyl having 1 to 40 carbon atoms, and "arylsilyl" refers to silyl substituted with aryl having 5 to 40 carbon atoms.
본 발명에서 "축합고리"는 축합 지방족 고리, 축합 방향족 고리, 축합 헤테로지방족 고리, 축합 헤테로방향족 고리 또는 이들의 조합된 형태를 의미한다.In the present invention, "condensed ring" means a condensed aliphatic ring, a condensed aromatic ring, a condensed heteroaliphatic ring, a condensed heteroaromatic ring, or a combination thereof.
2. 전자수송층2. Electron transport layer
본 발명에 따라 화학식 1로 표시되는 화합물은, 플루오렌의 9번 위치에 지방족 고리기, 예컨대 시클로헥실기가 스피로(spiro) 형태로 치환된 것을 코어(core)로 채택하고, 상기 코어 구조의 페닐기에 전자 수송능이 뛰어난 전자끄는기(electron withdrawing group: EWG)가 결합되어 전자를 받는 특성이 강하므로, 상기 화학식 1의 화합물을 전자수송층으로 적용시, 음극으로부터 전자를 잘 수용할 수 있으므로, 발광층으로 전자를 원활히 전달할 수 있다. 따라서, 본 발명은 상기 화학식 1로 표시되는 전자수송층용 화합물로 사용될 수 있다.In the compound represented by Formula 1 according to the present invention, an aliphatic ring group, for example, a cyclohexyl group substituted in a spiro form at the 9th position of fluorene is adopted as a core, and a phenyl group of the core structure is adopted. Since the electron withdrawing group (EWG) having excellent electron transport ability is combined with the electron-withdrawing group (EWG) to have strong electron-receiving properties, when the compound of Formula 1 is applied as an electron transport layer, it can well accept electrons from the cathode, so it is used as a light emitting layer Electrons can be transferred smoothly. Therefore, the present invention can be used as the compound for the electron transport layer represented by the formula (1).
전자수송층(ETL)은 음극에서 전자를 받아 발광층으로 전자를 이동시키는 역할을 한다. 이에 따라, 전자수송층에 사용되는 재료는 전자를 받는 특성이 강할수록, 전자를 이동시키는데 적합하다.The electron transport layer (ETL) serves to receive electrons from the cathode and move the electrons to the light emitting layer. Accordingly, the stronger the material used for the electron transport layer, the more suitable it is to move electrons.
구체적으로, 상기 전자수송층(ETL)은 음극에서 주입되는 전자를 인접하는 층, 구체적으로 발광층으로 이동시키는 역할을 하며, 상기 화학식 1로 표시되는 화합물은 전자수송층(ETL) 재료로서 단독으로 사용될 수 있으며, 또는 당 분야에 공지된 전자수송층 재료와 혼용될 수 있다.Specifically, the electron transport layer (ETL) serves to move electrons injected from the cathode to an adjacent layer, specifically, a light emitting layer, and the compound represented by Formula 1 may be used alone as an electron transport layer (ETL) material. , or may be mixed with an electron transport layer material known in the art.
상기 화학식 1의 화합물과 혼용될 수 있는 전자수송층 재료는, 당 분야에서 통상적으로 공지된 전자수송 물질을 포함하며, 사용 가능한 전자 수송 물질의 비제한적인 예로는 옥사졸계 화합물, 이소옥사졸계 화합물, 트리아졸계 화합물, 이소티아졸(isothiazole)계 화합물, 옥사디아졸계 화합물, 티아다아졸(thiadiazole)계 화합물, 페릴렌(perylene)계 화합물, 알루미늄 착물(예: Alq3 (트리스(8-퀴놀리놀라토)-알루미늄(tris(8-quinolinolato)-aluminium) BAlq, SAlq, Almq3, 갈륨 착물(예: Gaq'2OPiv, Gaq'2OAc, 2(Gaq'2)) 등이 있다. 이들을 단독으로 사용하거나 또는 2종 이상 혼용할 수 있다.The electron transport layer material that can be mixed with the compound of Formula 1 includes an electron transport material commonly known in the art, and non-limiting examples of the electron transport material that can be used include an oxazole-based compound, an isoxazole-based compound, and a tria. Sol-based compounds, isothiazole-based compounds, oxadiazole-based compounds, thiadiazole-based compounds, perylene-based compounds, aluminum complexes (eg, Alq3 (tris(8-quinolinolato) -aluminum (tris(8-quinolinolato)-aluminium) BAlq, SAlq, Almq3, gallium complex (eg Gaq'2OPiv, Gaq'2OAc, 2(Gaq'2)), etc. These may be used alone or in two types more can be mixed.
본 발명에서, 상기 화학식 1의 화합물과 전자수송층 재료를 혼용할 경우, 이들의 혼합 비율은 특별히 제한되지 않으며, 당 분야에 공지된 범위 내에서 적절히 조절될 수 있다.In the present invention, when the compound of Formula 1 and the electron transport layer material are mixed, their mixing ratio is not particularly limited and may be appropriately adjusted within a range known in the art.
3. 유기 전계 발광 소자3. Organic electroluminescent device
한편, 본 발명의 다른 측면은 상기한 본 발명에 따른 화학식 1로 표시되는 화합물을 포함하는 유기 전계 발광 소자(유기 EL 소자)에 관한 것이다.Meanwhile, another aspect of the present invention relates to an organic electroluminescent device (organic EL device) including the compound represented by Formula 1 according to the present invention.
구체적으로, 본 발명은 양극(anode), 음극(cathode), 및 상기 양극과 음극 사이에 개재(介在)된 1층 이상의 유기물층을 포함하는 유기 전계 발광 소자로서, 상기 1층 이상의 유기물층 중 적어도 하나는 상기 화학식 1로 표시되는 화합물을 포함한다. 이때, 상기 화합물은 단독 또는 2종 이상 혼합되어 사용될 수 있다.Specifically, the present invention is an organic electroluminescent device comprising an anode, a cathode, and one or more organic material layers interposed between the anode and the cathode, wherein at least one of the one or more organic material layers is and a compound represented by Formula 1 above. In this case, the compound may be used alone or in mixture of two or more.
상기 1층 이상의 유기물층은 정공 주입층, 정공 수송층, 발광층, 발광 보조층, 전자 수송층, 전자 수송 보조층 및 전자 주입층 중 어느 하나 이상일 수 있고, 이 중에서 적어도 하나의 유기물층은 상기 화학식 1로 표시되는 화합물을 포함한다. 구체적으로 상기 화학식 1의 화합물을 포함하는 유기물층은 발광층, 전자수송층, 전자수송 보조층인 것이 바람직하다.The one or more organic material layers may be any one or more of a hole injection layer, a hole transport layer, a light emitting layer, a light emission auxiliary layer, an electron transport layer, an electron transport auxiliary layer, and an electron injection layer, and at least one organic material layer is represented by Formula 1 including compounds. Specifically, it is preferable that the organic material layer including the compound of Formula 1 is a light emitting layer, an electron transport layer, and an electron transport auxiliary layer.
본 발명에 따른 유기 전계 발광 소자의 발광층은 호스트 재료와 도펀트 재료를 포함하는데, 이때 호스트 재료로서 상기 화학식 1의 화합물을 포함할 수 있다. 또한 본 발명의 발광층은 상기 화학식 1의 화합물 이외의 당 분야의 공지된 화합물을 호스트로서 포함할 수 있다.The light emitting layer of the organic electroluminescent device according to the present invention includes a host material and a dopant material, and in this case, the compound of Formula 1 may be included as the host material. In addition, the light emitting layer of the present invention may include a known compound in the art other than the compound of Formula 1 as a host.
상기 화학식 1로 표시되는 화합물을 유기 전계 발광 소자의 발광층 재료, 바람직하게는 청색, 녹색, 적색의 인광 호스트 재료로 포함할 경우, 발광층에서 정공과 전자의 결합력이 높아지기 때문에, 유기 전계 발광 소자의 효율(발광효율 및 전력효율), 수명, 휘도 및 구동전압 등을 향상시킬 수 있다. 구체적으로 상기 화학식 1로 표시되는 화합물은 녹색 및/또는 적색의 인광 호스트, 형광 호스트, 또는 도펀트 재료로서 유기 전계 발광 소자에 포함되는 것이 바람직하다. 특히, 본 발명의 화학식 1로 표시되는 화합물은 고효율을 가진 발광층의 그린 인광 exciplex N-type 호스트 재료인 것이 바람직하다.When the compound represented by Formula 1 is included as a light emitting layer material of an organic electroluminescent device, preferably a blue, green, or red phosphorescent host material, since the bonding force between holes and electrons in the light emitting layer is increased, the efficiency of the organic electroluminescent device (luminous efficiency and power efficiency), lifespan, luminance, and driving voltage can be improved. Specifically, the compound represented by Formula 1 is preferably included in the organic electroluminescent device as a green and/or red phosphorescent host, a fluorescent host, or a dopant material. In particular, the compound represented by Formula 1 of the present invention is preferably a green phosphorescent exciplex N-type host material of the light emitting layer having high efficiency.
이러한 본 발명의 유기 전계 발광 소자의 구조는 특별히 한정되지 않으나, 기판, 양극, 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 음극이 순차적으로 적층된 구조일 수 있다. 이때, 상기 정공주입층, 정공수송층, 발광보조층, 발광층, 전자수송층 및 전자주입층 중 하나 이상은 상기 화학식 1로 표시되는 화합물을 포함할 수 있고, 바람직하게는 발광층, 보다 바람직하게는 인광 호스트가 상기 화학식 1로 표시되는 화합물을 포함할 수 있다. 한편 상기 전자수송층 위에는 전자주입층이 추가로 적층될 수 있다.The structure of the organic electroluminescent device of the present invention is not particularly limited, but may be a structure in which a substrate, an anode, a hole injection layer, a hole transport layer, a light emitting auxiliary layer, a light emitting layer, an electron transport layer and a cathode are sequentially stacked. At this time, at least one of the hole injection layer, the hole transport layer, the light emitting auxiliary layer, the light emitting layer, the electron transport layer and the electron injection layer may include the compound represented by Formula 1, preferably the light emitting layer, more preferably a phosphorescent host may include a compound represented by Formula 1 above. Meanwhile, an electron injection layer may be additionally stacked on the electron transport layer.
본 발명의 유기 전계 발광 소자의 구조는 전극과 유기물층 계면에 절연층 또는 접착층이 삽입된 구조일 수 있다.The structure of the organic electroluminescent device of the present invention may be a structure in which an insulating layer or an adhesive layer is inserted at the interface between the electrode and the organic material layer.
본 발명의 유기 전계 발광 소자는, 전술한 유기물층 중 1층 이상이 상기 화학식 1로 표시되는 화합물을 포함하는 것을 제외하고는, 당 업계에 공지된 재료 및 방법으로 유기물층 및 전극을 형성하여 제조할 수 있다.The organic electroluminescent device of the present invention can be manufactured by forming an organic material layer and an electrode using materials and methods known in the art, except that at least one layer of the organic material layer includes the compound represented by Formula 1 above. have.
상기 유기물층은 진공 증착법이나 용액 도포법에 의하여 형성될 수 있다. 상기 용액 도포법의 예로는 스핀 코팅, 딥코팅, 닥터 블레이딩, 잉크젯 프린팅 또는 열 전사법 등이 있으나, 이에 한정되지는 않는다.The organic material layer may be formed by a vacuum deposition method or a solution coating method. Examples of the solution coating method include, but are not limited to, spin coating, dip coating, doctor blading, inkjet printing, or thermal transfer method.
본 발명의 유기 전계 발광 소자 제조시 사용되는 기판은 특별히 한정되지 않으며, 일례로 실리콘 웨이퍼, 석영, 유리판, 금속판, 플라스틱 필름 및 시트 등을 사용할 수 있다.The substrate used in manufacturing the organic electroluminescent device of the present invention is not particularly limited, and for example, a silicon wafer, quartz, a glass plate, a metal plate, a plastic film, and a sheet may be used.
또, 양극 물질은 당 분야에 공지된 양극 물질을 제한 없이 사용할 수 있다. 일례를 들면, 바나듐, 크롬, 구리, 아연, 금과 같은 금속 또는 이들의 합금; 아연산화물, 인듐산화물, 인듐 주석 산화물(ITO), 인듐 아연 산화물(IZO)과 같은 금속 산화물; ZnO:Al 또는 SnO2:Sb와 같은 금속과 산화물의 조합; 폴리티오펜, 폴리(3-메틸티오펜), 폴리[3,4-(에틸렌-1,2-디옥시)티오펜](PEDT), 폴리피롤 또는 폴리아닐린과 같은 전도성 고분자; 및 카본블랙 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as the cathode material, a cathode material known in the art may be used without limitation. For example, metals such as vanadium, chromium, copper, zinc, gold, or alloys thereof; metal oxides such as zinc oxide, indium oxide, indium tin oxide (ITO), and indium zinc oxide (IZO); combinations of metals and oxides such as ZnO:Al or SnO2:Sb; conductive polymers such as polythiophene, poly(3-methylthiophene), poly[3,4-(ethylene-1,2-dioxy)thiophene](PEDT), polypyrrole or polyaniline; and carbon black, but is not limited thereto.
또, 음극 물질은 당 분야에 공지된 음극 물질을 제한 없이 사용할 수 있다. 일례를 들면, 마그네슘, 칼슘, 나트륨, 칼륨, 타이타늄, 인듐, 이트륨, 리튬, 가돌리늄, 알루미늄, 은, 주석, 또는 납과 같은 금속 또는 이들의 합금; 및 LiF/Al 또는 LiO2/Al과 같은 다층 구조 물질 등을 들 수 있으나, 이에 한정되지는 않는다.In addition, as the negative electrode material, any negative electrode material known in the art may be used without limitation. For example, a metal such as magnesium, calcium, sodium, potassium, titanium, indium, yttrium, lithium, gadolinium, aluminum, silver, tin, or lead or an alloy thereof; and a multilayer structure material such as LiF/Al or LiO2/Al, but is not limited thereto.
또한, 정공 주입층, 정공 수송층, 전자 주입층 및 전자 수송층은 특별히 한정되는 것은 아니며, 당 업계에 공지된 통상의 물질을 제한 없이 사용할 수 있다.In addition, the hole injection layer, the hole transport layer, the electron injection layer and the electron transport layer are not particularly limited, and conventional materials known in the art may be used without limitation.
이하 본 발명을 실시예를 통하여 상세히 설명하면 다음과 같다. 단, 하기 실시예는 본 발명을 예시하는 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in detail through examples. However, the following examples only illustrate the present invention, and the present invention is not limited by the following examples.
[준비예 1] 7'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]의 합성[Preparation Example 1] Synthesis of 7'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2-bromo-9,9-dimethyl-9H-fluorene (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] (42.05 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2 -bromo-9,9-dimethyl-9H-fluorene (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were mixed with 1000 ml of Toluene, Ethanol 250ml, put into 250ml of H 2 O, heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene was used by column chromatography. ] (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.74(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(d, 1H), 7.28(t, 1H), 7.38(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.74(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55 (d, 1H), 7.28 (t, 1H), 7.38 (t, 1H), 7.90 (d, 1H), 8.09 (d, 1H), 7.78 (d, 1H)
[LCMS] : 461 [LCMS]: 461
상기와 같은 방법으로, 2-bromo-9,9-dimethyl-9H-fluorene 대신 4-bromo-9,9-dimethyl-9H-fluorene 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene] 혹은 4'-bromospiro[cyclohexane-1,9'-fluorene]을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, instead of 2-bromo-9,9-dimethyl-9H-fluorene, 4-bromo-9,9-dimethyl-9H-fluorene or 2'-bromospiro [cyclohexane-1,9'-fluorene] or By using 4'-bromospiro [cyclohexane-1,9'-fluorene], the following target compound can be synthesized.
[준비예 2] 6'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]의 합성[Preparation Example 2] Synthesis of 6'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]
2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2-bromo-9,9-dimethyl-9H-fluorene (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 6'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] (42.05 g, 수율 72 %)을 얻었다.2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2 -bromo-9,9-dimethyl-9H-fluorene (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were mixed with 1000 ml of Toluene, Ethanol 250ml, put into 250ml of H 2 O, heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 6'-chloro-3'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene was used by column chromatography. ] (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.76(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(d, 1H), 7.28(t, 1H), 7.38(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.76(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55 (d, 1H), 7.28 (t, 1H), 7.38 (t, 1H), 7.90 (d, 1H), 8.09 (d, 1H), 7.78 (d, 1H)
[LCMS] : 461 [LCMS]: 461
상기와 같은 방법으로, 2-bromo-9,9-dimethyl-9H-fluorene 대신 4-bromo-9,9-dimethyl-9H-fluorene 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene] 혹은 4'-bromospiro[cyclohexane-1,9'-fluorene]을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, instead of 2-bromo-9,9-dimethyl-9H-fluorene, 4-bromo-9,9-dimethyl-9H-fluorene or 2'-bromospiro [cyclohexane-1,9'-fluorene] or By using 4'-bromospiro [cyclohexane-1,9'-fluorene], the following target compound can be synthesized.
[준비예 3] 7'-chloro-2'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]의 합성[Preparation Example 3] Synthesis of 7'-chloro-2'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene]
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2-bromo-9,9-dimethyl-9H-fluorene (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7'-chloro-2'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene] (42.05 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 2 -bromo-9,9-dimethyl-9H-fluorene (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were mixed with 1000 ml of Toluene, Ethanol 250ml, put into 250ml of H 2 O, heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7'-chloro-2'-(9,9-dimethyl-9H-fluoren-2-yl)spiro[cyclohexane-1,9'-fluorene was used by column chromatography. ] (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.75(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(d, 1H), 7.28(t, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.75(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55 (d, 1H), 7.28 (t, 1H), 7.48 (t, 1H), 7.90 (d, 1H), 8.09 (d, 1H), 7.78 (d, 1H)
[LCMS] : 461 [LCMS]: 461
상기와 같은 방법으로, 2-bromo-9,9-dimethyl-9H-fluorene 대신 4-bromo-9,9-dimethyl-9H-fluorene 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene] 혹은 4'-bromospiro[cyclohexane-1,9'-fluorene]을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, instead of 2-bromo-9,9-dimethyl-9H-fluorene, 4-bromo-9,9-dimethyl-9H-fluorene or 2'-bromospiro [cyclohexane-1,9'-fluorene] or By using 4'-bromospiro [cyclohexane-1,9'-fluorene], the following target compound can be synthesized.
[준비예 4] 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile의 합성[Preparation Example 4] Synthesis of 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile (42.05 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7 -bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) 1000ml of Toluene, 250ml of Ethanol, 250ml of H 2 O It was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene was used by column chromatography. -2-carbonitrile (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.75(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.75(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H)
[LCMS] : 486 [LCMS]: 486
상기와 같은 방법으로, 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 대신 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile 혹은 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same manner as above, 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile or 2'-bromospiro[cyclohexane-] instead of 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile Using 1,9'-fluorene]-7'-carbonitrile or 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile, the following target compound can be synthesized.
[준비예 5] 7-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile의 합성[Preparation Example 5] Synthesis of 7-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile
2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile (42.05 g, 수율 72 %)을 얻었다.2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7 -bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) 1000ml of Toluene, 250ml of Ethanol, 250ml of H 2 O It was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-9,9-dimethyl-9H-fluorene was used by column chromatography. -2-carbonitrile (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.39(d, 1H), 7.84(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H)
[LCMS] : 486 [LCMS]: 486
상기와 같은 방법으로, 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 대신 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile 혹은 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same manner as above, 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile or 2'-bromospiro[cyclohexane-] instead of 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile Using 1,9'-fluorene]-7'-carbonitrile or 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile, the following target compound can be synthesized.
[준비예 6] 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile의 합성[Preparation Example 6] Synthesis of 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-9,9-dimethyl-9H-fluorene-2-carbonitrile (42.05 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 7 -bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile (34.6 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) 1000ml of Toluene, 250ml of Ethanol, 250ml of H 2 O It was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 7-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-9,9-dimethyl-9H-fluorene was used by column chromatography. -2-carbonitrile (42.05 g, yield 72%) was obtained.
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.41(d, 1H), 7.86(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m, 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.41(d, 1H), 7.86(d, 1H), 8.18(s, 1H), 7.89(s, 1H), 1.60(m) , 2H), 7.55(s, 1H), 7.48(t, 1H), 7.90(d, 1H), 8.09(d, 1H), 7.78(d, 1H)
[LCMS] : 486 [LCMS]: 486
상기와 같은 방법으로, 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 대신 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile 혹은, 2'-bromospiro[cyclohexane-1,9'-fluorene]-7'-carbonitrile 혹은 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same manner as above, 5-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile or 2'-bromospiro[cyclohexane-] instead of 7-bromo-9,9-dimethyl-9H-fluorene-2-carbonitrile Using 1,9'-fluorene]-7'-carbonitrile or 5'-bromospiro[cyclohexane-1,9'-fluorene]-2'-carbonitrile, the following target compound can be synthesized.
[준비예 7] 4-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile의 합성[Preparation Example 7] Synthesis of 4-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 4-bromobenzonitrile (23.06g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 4-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile (33.73 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 4 -bromobenzonitrile (23.06 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were added to 1000 ml of Toluene, 250 ml of Ethanol, 250 ml of H 2 O, and 12 hours It was heated and refluxed for a while. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound, 4-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile (33.73 g, yield 72%), was obtained by column chromatography. got it
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.40(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d, 1H), 7.65(d, 1H), 7.67(d, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.40(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d) , 1H), 7.65 (d, 1H), 7.67 (d, 1H)
[LCMS] : 369[LCMS]: 369
상기와 같은 방법으로, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 혹은, 2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane instead of 2- (2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane or 2-(3'-chlorospiro[cyclohexane -1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane can be used to synthesize the target compound as follows.
[준비예 8] 8-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline의 합성[Preparation Example 8] Synthesis of 8-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 8-bromo-4a,5-dihydroquinoline (26.61g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 8-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline (33.73 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 8 -bromo-4a,5-dihydroquinoline (26.61 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were mixed with 1000 ml of Toluene, 250 ml of Ethanol, and H 2 O 250ml and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound 8-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline (33.73 g, yield 72%) was obtained by column chromatography. got it
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.40(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d, 1H), 7.65(d, 1H), 7.67(d, 1H), 7.66(t, 1H), 7.69(t, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.40(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d) , 1H), 7.65 (d, 1H), 7.67 (d, 1H), 7.66 (t, 1H), 7.69 (t, 1H)
[LCMS] : 395[LCMS]: 395
상기와 같은 방법으로, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 혹은, 2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane instead of 2- (2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane or 2-(3'-chlorospiro[cyclohexane -1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane can be used to synthesize the following target compound.
[준비예 9] 5-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline의 합성[Preparation Example 9] Synthesis of 5-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline
2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 5-bromoquinoline (26.61g, 126.66 mmol)및 Pd(PPh3)4 (7.32 g, 6.33 mmol), K2CO3 (35.01 g, 253.32 mmol)을 Toluene 1000ml, Ethanol 250ml, H2O 250ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 5-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline (33.73 g, 수율 72 %)을 얻었다.2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane (50.0 g, 126.66 mmol), 5 -bromoquinoline (26.61 g, 126.66 mmol) and Pd(PPh 3 ) 4 (7.32 g, 6.33 mmol), K 2 CO 3 (35.01 g, 253.32 mmol) were added to 1000 ml of Toluene, 250 ml of Ethanol, 250 ml of H 2 O, and 12 hours It was heated and refluxed for a while. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound, 5-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline (33.73 g, yield 72%), was obtained by column chromatography. got it
1H-NMR: δ 1.44(t, 1H), 1.46(t, 1H), 1.43(t, 2H), 1.53(t, 2H), 1.90(t, 2H), 2.15(t, 2H), 7.56(s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.39(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d, 1H), 7.65(d, 1H), 7.64(d, 1H), 7.62(t, 1H), 7.69(t, 1H) 1 H-NMR: δ 1.44 (t, 1H), 1.46 (t, 1H), 1.43 (t, 2H), 1.53 (t, 2H), 1.90 (t, 2H), 2.15 (t, 2H), 7.56 ( s, 1H), 7.73(d, 1H), 7.68(d, 1H), 7.39(s, 1H), 7.84(d, 1H), 7.86(d, 1H), 7.89(d, 1H), 7.90(d) , 1H), 7.65 (d, 1H), 7.64 (d, 1H), 7.62 (t, 1H), 7.69 (t, 1H)
[LCMS] : 395[LCMS]: 395
상기와 같은 방법으로, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 대신 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 혹은, 2-(3'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane 을 사용하여 하기와 같은 목적화합물을 합성할 수 있다.In the same way as above, 2-(2'-chlorospiro[cyclohexane-1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane instead of 2- (2'-chlorospiro[cyclohexane-1,9'-fluoren]-7'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane or 2-(3'-chlorospiro[cyclohexane -1,9'-fluoren]-6'-yl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane can be used to synthesize the target compound as follows.
* 합성예* Synthesis example
[합성예 1] 화합물 A-1의 합성[Synthesis Example 1] Synthesis of compound A-1
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 18.10mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) 및 Pd(PPh3)4 (1.05 g, 0.9 mmol), K2CO3 (5 g, 36.19 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-1 (8.57g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 18.10mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) and Pd(PPh 3 ) 4 (1.05 g, 0.9 mmol), K 2 CO 3 (5 g, 36.19 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-1 (8.57 g, yield 72%) was obtained by column chromatography.
[LCMS] : 657[LCMS]: 657
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-1, C-1, D-1, E-1, F-1, G-1, H-1를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-1, C-1, D-1, E-1, F-1, G-1, respectively , H-1 can be synthesized.
[합성예 2] 화합물 A-2의 합성[Synthesis Example 2] Synthesis of compound A-2
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 18.10mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) 및 Pd(PPh3)4 (1.05 g, 0.9 mmol), K2CO3 (5 g, 36.19 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-2 (8.57g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 18.10mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) and Pd(PPh 3 ) 4 (1.05 g, 0.9 mmol), K 2 CO 3 (5 g, 36.19 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-2 (8.57 g, yield 72%) was obtained by column chromatography.
[LCMS] : 657[LCMS]: 657
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-2, C-2, D-2, E-2, F-2, G-2, H-2를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-2, C-2, D-2, E-2, F-2, G-2, respectively , H-2 can be synthesized.
[합성예 3] 화합물 A-3의 합성[Synthesis Example 3] Synthesis of compound A-3
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.87mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) 및 Pd(PPh3)4 (0.97 g, 0.84 mmol), K2CO3 (4.66 g, 33.75 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-3 (8.48g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.87mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) and Pd(PPh 3 ) 4 (0.97 g, 0.84 mmol), K 2 CO 3 (4.66 g, 33.75 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-3 (8.48 g, yield 72%) was obtained by column chromatography.
[LCMS] : 697[LCMS]: 697
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-3, C-3, D-3, E-3, F-3, G-3, H-3를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-3, C-3, D-3, E-3, F-3, G-3, respectively , H-3 can be synthesized.
[합성예 4] 화합물 A-4의 합성[Synthesis Example 4] Synthesis of compound A-4
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.87mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) 및 Pd(PPh3)4 (0.97 g, 0.84 mmol), K2CO3 (4.66 g, 33.75 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-4 (8.48g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.87mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) and Pd(PPh 3 ) 4 (0.97 g, 0.84 mmol), K 2 CO 3 (4.66 g, 33.75 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-4 (8.48 g, yield 72%) was obtained by column chromatography.
[LCMS] : 697[LCMS]: 697
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-4, C-4, D-4, E-4, F-4, G-4, H-4를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-4, C-4, D-4, E-4, F-4, G-4, respectively , H-4 can be synthesized.
[합성예 5] 화합물 A-5의 합성[Synthesis Example 5] Synthesis of compound A-5
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 18.10mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) 및 Pd(PPh3)4 (1.05 g, 0.9 mmol), K2CO3 (5 g, 36.19 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-5 (8.57g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 18.10mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) and Pd(PPh 3 ) 4 (1.05 g, 0.9 mmol), K 2 CO 3 (5 g, 36.19 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-5 (8.57 g, yield 72%) was obtained by column chromatography.
[LCMS] : 657[LCMS]: 657
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-5, C-5, D-5, E-5, F-5, G-5, H-5를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-5, C-5, D-5, E-5, F-5, G-5, respectively , H-5 can be synthesized.
[합성예 6] 화합물 A-6의 합성[Synthesis Example 6] Synthesis of compound A-6
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 18.10mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) 및 Pd(PPh3)4 (1.05 g, 0.9 mmol), K2CO3 (5 g, 36.19 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-6 (8.57g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 18.10mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.84 g, 18.10 mmol) and Pd(PPh 3 ) 4 (1.05 g, 0.9 mmol), K 2 CO 3 (5 g, 36.19 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-6 (8.57 g, yield 72%) was obtained by column chromatography.
[LCMS] : 657[LCMS]: 657
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-6, C-6, D-6, E-6, F-6, G-6, H-6를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-6, C-6, D-6, E-6, F-6, G-6, respectively , H-6 can be synthesized.
[합성예 7] 화합물 A-7의 합성[Synthesis Example 7] Synthesis of compound A-7
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.87mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) 및 Pd(PPh3)4 (0.97 g, 0.84 mmol), K2CO3 (4.66 g, 33.75 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-3 (8.48g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.87mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) and Pd(PPh 3 ) 4 (0.97 g, 0.84 mmol), K 2 CO 3 (4.66 g, 33.75 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-3 (8.48 g, yield 72%) was obtained by column chromatography.
[LCMS] : 697[LCMS]: 697
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-7, C-7, D-7, E-7, F-7, G-7, H-7를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-7, C-7, D-7, E-7, F-7, G-7, respectively , H-7 can be synthesized.
[합성예 8] 화합물 A-8의 합성[Synthesis Example 8] Synthesis of compound A-8
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.87mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) 및 Pd(PPh3)4 (0.97 g, 0.84 mmol), K2CO3 (4.66 g, 33.75 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-4 (8.48g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.87mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.52 g, 16.87 mmol) and Pd(PPh 3 ) 4 (0.97 g, 0.84 mmol), K 2 CO 3 (4.66 g, 33.75 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-4 (8.48 g, yield 72%) was obtained by column chromatography.
[LCMS] : 697[LCMS]: 697
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-8, C-8, D-8, E-8, F-8, G-8, H-8를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-8, C-8, D-8, E-8, F-8, G-8, respectively , H-8 can be synthesized.
[합성예 9] 화합물 A-9의 합성[Synthesis Example 9] Synthesis of compound A-9
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-9 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-9 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-9, C-9, D-9, E-9, F-9, G-9, H-9를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-9, C-9, D-9, E-9, F-9, G-9, respectively , H-9 can be synthesized.
[합성예 10] 화합물 A-10의 합성[Synthesis Example 10] Synthesis of compound A-10
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-10 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-10 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-10, C-10, D-10, E-10, F-10, G-10, H-10를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-10, C-10, D-10, E-10, F-10, G-10, respectively , H-10 can be synthesized.
[합성예 11] 화합물 A-11의 합성[Synthesis Example 11] Synthesis of compound A-11
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-11 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-11 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-11, C-11, D-11, E-11, F-11, G-11, H-11를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-11, C-11, D-11, E-11, F-11, G-11, respectively , H-11 can be synthesized.
[합성예 12] 화합물 A-12의 합성[Synthesis Example 12] Synthesis of compound A-12
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-12 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-12 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-12, C-12, D-12, E-12, F-12, G-12, H-12를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-12, C-12, D-12, E-12, F-12, G-12, respectively , H-12 can be synthesized.
[합성예 13] 화합물 A-13의 합성[Synthesis Example 13] Synthesis of compound A-13
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-13 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-13 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-13, C-13, D-13, E-13, F-13, G-13, H-13를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-13, C-13, D-13, E-13, F-13, G-13 , H-13 can be synthesized.
[합성예 14] 화합물 A-14의 합성[Synthesis Example 14] Synthesis of compound A-14
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-14 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-14 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-14, C-14, D-14, E-14, F-14, G-14, H-14를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-14, C-14, D-14, E-14, F-14, G-14, respectively , H-14 can be synthesized.
[합성예 15] 화합물 A-15의 합성[Synthesis Example 15] Synthesis of compound A-15
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-15 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-15 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-15, C-15, D-15, E-15, F-15, G-15, H-15를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-15, C-15, D-15, E-15, F-15, G-15, respectively , H-15 can be synthesized.
[합성예 16] 화합물 A-16의 합성[Synthesis Example 16] Synthesis of compound A-16
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-16 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-16 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-16, C-16, D-16, E-16, F-16, G-16, H-16를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-16, C-16, D-16, E-16, F-16, G-16, respectively , H-16 can be synthesized.
[합성예 17] 화합물 A-17의 합성[Synthesis Example 17] Synthesis of compound A-17
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-17 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-17 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-17, C-17, D-17, E-17, F-17, G-17, H-17를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-17, C-17, D-17, E-17, F-17, G-17, respectively , H-17 can be synthesized.
[합성예 18] 화합물 A-18의 합성[Synthesis Example 18] Synthesis of compound A-18
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 17.93 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) 및 Pd(PPh3)4 (1.04 g, 0.90 mmol), K2CO3 (4.96 g, 35.87 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-18 (8.82g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 17.93 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.80 g, 17.93 mmol) and Pd(PPh 3 ) 4 (1.04 g, 0.90 mmol), K 2 CO 3 (4.96 g, 35.87 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-18 (8.82 g, yield 72%) was obtained by column chromatography.
[LCMS] : 682[LCMS]: 682
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-18, C-18, D-18, E-18, F-18, G-18, H-18를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-18, C-18, D-18, E-18, F-18, G-18, respectively , H-18 can be synthesized.
[합성예 19] 화합물 A-19의 합성[Synthesis Example 19] Synthesis of compound A-19
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-19 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-19 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-19, C-19, D-19, E-19, F-19, G-19, H-19를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-19, C-19, D-19, E-19, F-19, G-19, respectively , H-19 can be synthesized.
[합성예 20] 화합물 A-20의 합성[Synthesis Example 20] Synthesis of compound A-20
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.19 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) 및 Pd(PPh3)4 (0.94 g, 0.81 mmol), K2CO3 (4.48 g, 32.38 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-20 (8.43g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.19 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.33 g, 16.19 mmol) and Pd(PPh 3 ) 4 (0.94 g, 0.81 mmol), K 2 CO 3 (4.48 g, 32.38 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-20 (8.43 g, yield 72%) was obtained by column chromatography.
[LCMS] : 722[LCMS] : 722
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-20, C-20, D-20, E-20, F-20, G-20, H-20를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-20, C-20, D-20, E-20, F-20, G-20, respectively , H-20 can be synthesized.
[합성예 21] 화합물 A-21의 합성[Synthesis Example 21] Synthesis of compound A-21
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 21.67 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (5.8 g, 21.67 mmol) 및 Pd(PPh3)4 (1.25 g, 1.08 mmol), K2CO3 (5.99 g, 43.35 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-21 (8.84g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 21.67 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (5.8 g, 21.67 mmol) and Pd(PPh 3 ) 4 (1.25 g, 1.08 mmol), K 2 CO 3 (5.99 g, 43.35 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-21 (8.84 g, yield 72%) was obtained by column chromatography.
[LCMS] : 566[LCMS]: 566
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-21, C-21, D-21, E-21, F-21, G-21, H-21를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-21, C-21, D-21, E-21, F-21, G-21, respectively , H-21 can be synthesized.
또한 준비된 화합물을 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)benzonitrile 대신 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-24, B-24, C-24, D-24, E-24, F-24, G-24, H-24를 합성할 수 있다.In addition, the prepared compound was 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) Use 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile instead of benzonitrile 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-24, B-24, C-24, D-24, E-24, F-24, G -24 and H-24 can be synthesized.
또한 준비된 화합물을 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)benzonitrile 대신 4-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile 을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-27, B-27, C-27, D-27, E-27, F-27, G-27, H-27를 합성할 수 있다.In addition, the prepared compound was 4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) Use 4-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)benzonitrile instead of benzonitrile 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-27, B-27, C-27, D-27, E-27, F-27, G -27 and H-27 can be synthesized.
[합성예 22] 화합물 A-22의 합성[Synthesis Example 22] Synthesis of compound A-22
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 20.51 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (5.49 g, 20.51 mmol) 및 Pd(PPh3)4 (1.19 g, 1.03 mmol), K2CO3 (5.67 g, 41.03 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-22 (8.84g, 수율 72 %)을 얻었다.Prepare the compound of the preparation example with the target compound (10g, 20.51 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (5.49 g, 20.51 mmol) and Pd(PPh 3 ) 4 (1.19 g, 1.03 mmol), K 2 CO 3 (5.67 g, 41.03 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-22 (8.84 g, yield 72%) was obtained by column chromatography.
[LCMS] : 592[LCMS]: 592
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-22, C-22, D-22, E-22, F-22, G-22, H-22를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-22, C-22, D-22, E-22, F-22, G-22, respectively , H-22 can be synthesized.
또한 준비된 화합물을 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)quinoline 대신 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-25, B-25, C-25, D-25, E-25, F-25, G-25, H-25를 합성할 수 있다.In addition, the prepared compound was 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline instead of quinoline 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-25, B-25, C-25, D-25, E-25, F-25, G -25 and H-25 can be synthesized.
또한 준비된 화합물을 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)quinoline 대신 8-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline 을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-28, B-28, C-28, D-28, E-28, F-28, G-28, H-28를 합성할 수 있다.In addition, the prepared compound was 8-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) 8-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline instead of quinoline 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-28, B-28, C-28, D-28, E-28, F-28, G -28 and H-28 can be synthesized.
[합성예 23] 화합물 A-23의 합성[Synthesis Example 23] Synthesis of compound A-23
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 20.51 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (5.49 g, 20.51 mmol) 및 Pd(PPh3)4 (1.19 g, 1.03 mmol), K2CO3 (5.67 g, 41.03 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-23 (8.84g, 수율 72 %)을 얻었다.Prepare the compound of the preparation example with the target compound (10g, 20.51 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (5.49 g, 20.51 mmol) and Pd(PPh 3 ) 4 (1.19 g, 1.03 mmol), K 2 CO 3 (5.67 g, 41.03 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O, and the mixture was heated and refluxed for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-23 (8.84 g, yield 72%) was obtained by column chromatography.
[LCMS] : 592[LCMS]: 592
상기 합성 방법과 같이 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 B-23, C-23, D-23, E-23, F-23, G-23, H-23를 합성할 수 있다.As in the above synthesis method, 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)- instead of 2-chloro-4,6-diphenyl-1,3,5-triazine 6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6 -triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d] When using pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, B-23, C-23, D-23, E-23, F-23, G-23, respectively , H-23 can be synthesized.
또한 준비된 화합물을 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)quinoline 대신 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-26, B-26, C-26, D-26, E-26, F-26, G-26, H-26를 합성할 수 있다.In addition, the prepared compound was 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline instead of quinoline 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-26, B-26, C-26, D-26, E-26, F-26, G -26 and H-26 can be synthesized.
또한 준비된 화합물을 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)quinoline 대신 5-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-29, B-29, C-29, D-29, E-29, F-29, G-29, H-29를 합성할 수 있다.In addition, the prepared compound was 5-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl) 5-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)quinoline instead of quinoline 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6- chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or When using 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, A-29, B-29, C-29, D-29, E-29, F-29, G -29 and H-29 can be synthesized.
[합성예 24] 화합물 A-30의 합성[Synthesis Example 24] Synthesis of compound A-30
준비예의 화합물을 Miyaura Borylation Reaction을 통해 얻은 목적화합물 (10g, 16.90 mmol)과 2-chloro-4,6-diphenyl-1,3,5-triazine (4.53 g, 16.90 mmol) 및 Pd(PPh3)4 (0.98 g, 0.85 mmol), K2CO3 (4.67 g, 33.81 mmol)을 Toluene 200ml, EtOH 50ml, H2O 50ml에 넣고 12시간동안 가열환류하였다. 반응 종결 후 메틸렌클로라이드로 추출하고 MgSO4를 넣고 필터하였다. 필터된 유기층의 용매를 제거한 후 컬럼크로마토그래피를 이용하여 목적 화합물인 A-30 (8.48g, 수율 72 %)을 얻었다.The compound of the preparation example is the target compound (10g, 16.90 mmol) obtained through Miyaura Borylation Reaction, 2-chloro-4,6-diphenyl-1,3,5-triazine (4.53 g, 16.90 mmol) and Pd(PPh 3 ) 4 (0.98 g, 0.85 mmol), K 2 CO 3 (4.67 g, 33.81 mmol) was added to 200 ml of Toluene, 50 ml of EtOH, and 50 ml of H 2 O and heated to reflux for 12 hours. After completion of the reaction, extraction was performed with methylene chloride, and MgSO 4 was added thereto and filtered. After removing the solvent of the filtered organic layer, the target compound A-30 (8.48 g, yield 72%) was obtained by column chromatography.
[LCMS] : 696[LCMS]: 696
상기 합성 방법과 같이 2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)-1,3,5-triazine 대신 2,4-diphenyl-6-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)-1,3,5-triazine 혹은 2,4-diphenyl-6-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)-1,3,5-triazine을 사용하고, 2-chloro-4,6-diphenyl-1,3,5-triazine 대신 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 A-30~68를 합성할 수 있다.2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren as in the above synthesis method ]-7'-yl)-1,3,5-triazine instead of 2,4-diphenyl-6-(3'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) )spiro[cyclohexane-1,9'-fluoren]-7'-yl)-1,3,5-triazine or 2,4-diphenyl-6-(3'-(4,4,5,5-tetramethyl- 1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-6'-yl)-1,3,5-triazine was used, and 2-chloro-4,6-diphenyl -1,3,5-triazine instead of 4-chloro-2,6-diphenylpyrimidine or 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 2-([1, 1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[ 1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine or 2-chloro-4-phenylbenzo[4,5] If thieno[2,3-d]pyrimidine is used, A-30~68 can be synthesized, respectively.
같은 방법으로, 2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)-1,3,5-triazine 대신, 2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-2-phenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrimidine 혹은 2,3,5-triphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrazine 혹은 6,8-diphenyl-2-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)-[1,2,4]triazolo[1,5-a]pyridine 혹은 2-phenyl-4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)benzo[4,5]thieno[3,2-d]pyrimidine 혹은 4-phenyl-2-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)benzo[4,5]thieno[2,3-d]pyrimidine와 같은 준비화합물과 2-chloro-4,6-diphenyl-1,3,5-triazine 혹은 4-chloro-2,6-diphenylpyrimidine 혹은 4-([1,1'-biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine 혹은 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine 혹은 2-chloro-3,5,6-triphenylpyrazine 혹은 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine 혹은 4-chloro-2-phenylbenzo[4,5]thieno[3,2-d]pyrimidine 혹은 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine을 사용하면 각각 I-1~16, J-1~18, K-1~30을 합성할 수 있다.In the same way, 2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren] Instead of -7'-yl)-1,3,5-triazine, 2,4-diphenyl-6-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl) )spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrimidine or 4-([1,1'-biphenyl]-4-yl)-2-phenyl-6-(2'-(4, 4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrimidine or 2,3,5-triphenyl-6-( 2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)pyrazine or 6,8-diphenyl -2-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)-[1 ,2,4]triazolo[1,5-a]pyridine or 2-phenyl-4-(2'-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[ cyclohexane-1,9'-fluoren]-7'-yl)benzo[4,5]thieno[3,2-d]pyrimidine or 4-phenyl-2-(2'-(4,4,5,5- Preparation compounds such as tetramethyl-1,3,2-dioxaborolan-2-yl)spiro[cyclohexane-1,9'-fluoren]-7'-yl)benzo[4,5]thieno[2,3-d]pyrimidine and 2-chloro-4,6-diphenyl-1,3,5-triazine or 4-chloro-2,6-diphenylpyrimidine or 4-([1,1' -biphenyl]-4-yl)-6-chloro-2-phenylpyrimidine or 2-([1,1'-biphenyl]-4-yl)-4-chloro-6-phenyl-1,3,5-triazine or 2-chloro-3,5,6-triphenylpyrazine or 2-chloro-6,8-diphenyl-[1,2,4]triazolo[1,5-a]pyridine or 4-chloro-2-phenylbenzo[4,5 When using ]thieno[3,2-d]pyrimidine or 2-chloro-4-phenylbenzo[4,5]thieno[2,3-d]pyrimidine, I-1~16, J-1~18, K- 1 to 30 can be synthesized.
* 소자예(소자평가 결과)* Device example (device evaluation result)
[실시예 1~39] 녹색 유기 EL 소자의 제작[Examples 1-39] Preparation of green organic EL device
화합물 A-17~23, B-17~20, C-17~23, D-17~23, E-17~23, G-17~23을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후 아래의 과정에 따라 녹색 유기 EL 소자를 제작하였다.Compounds A-17~23, B-17~20, C-17~23, D-17~23, E-17~23, G-17~23 are purified by sublimation with high purity by a commonly known method, and then A green organic EL device was fabricated according to the procedure.
먼저, ITO (Indium tin oxide)가 1500 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후 UV OZONE 세정기 (Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, ITO (Indium tin oxide) is 1500 The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, it is ultrasonically cleaned with a solvent such as isopropyl alcohol, acetone, methanol, etc., dried, transferred to a UV OZONE cleaner (Power sonic 405, Hwashin Tech), and then the substrate is cleaned using UV for 5 minutes and vacuum evaporator The substrate was transferred to
이렇게 준비된 ITO 투명 전극 위에 m-MTDATA (60 nm)/TCTA (80 nm)/ A-17~23, B-17~20, C-17~23, D-17~23, E-17~23, G-17~23의 각각의 화합물 + 10 % Ir(ppy)3 (30nm)/BCP (10 nm)/Alq3 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 EL 소자를 제작하였다. On the prepared ITO transparent electrode, m-MTDATA (60 nm)/TCTA (80 nm)/ A-17~23, B-17~20, C-17~23, D-17~23, E-17~23, Each compound of G-17~23 + 10% Ir(ppy) 3 (30 nm)/BCP (10 nm)/Alq 3 (30 nm)/LiF (1 nm)/Al (200 nm) layered in order An EL device was fabricated.
m-MTDATA, TCTA, Ir(ppy)3, CBP 및 BCP의 구조는 하기와 같다.The structures of m-MTDATA, TCTA, Ir(ppy) 3 , CBP and BCP are as follows.
[비교예1] 녹색 유기 EL 소자의 제작[Comparative Example 1] Preparation of green organic EL device
발광층 형성시 발광 호스트 물질로서 화합물 A-17 대신 CBP를 사용하는 것을 제외하고는 실시예 1과 동일한 과정으로 녹색 유기 EL 소자를 제작하였다.A green organic EL device was manufactured in the same manner as in Example 1, except that CBP was used instead of Compound A-17 as a light emitting host material when the light emitting layer was formed.
[평가예1][Evaluation Example 1]
실시예 1 ~ 39 및 비교예 1에서 제작한 각각의 녹색 유기 EL 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 1에 나타내었다.For each green organic EL device manufactured in Examples 1 to 39 and Comparative Example 1, the driving voltage, current efficiency, and emission peak at a current density of (10) mA/cm 2 were measured, and the results are shown in Table 1 below. it was
(V)drive voltage
(V)
(nm)EL peak
(nm)
(cd/A)current efficiency
(cd/A)
상기 표1에 나타낸 바와 같이, 본 발명에 따른 화합물 A-17~23, B-17~20, C-17~23, D-17~23, E-17~23, G-17~23을 녹색 유기 EL 소자의 발광층으로 사용하였을 경우(실시예 1~39) 종래 CBP를 사용한 녹색 유기 EL 소자(비교예1)와 비교해 볼 때 효율 및 구동전압 면에서 보다 우수한 성능을 나타내는 것을 알 수 있다.As shown in Table 1 above, compounds A-17 to 23, B-17 to 20, C-17 to 23, D-17 to 23, E-17 to 23, G-17 to 23 according to the present invention are green When used as a light emitting layer of an organic EL device (Examples 1 to 39), it can be seen that compared to a green organic EL device using conventional CBP (Comparative Example 1), it shows better performance in terms of efficiency and driving voltage.
[실시예 40~142] 청색 유기 전계 발광 소자의 제작[Examples 40 to 142] Fabrication of blue organic electroluminescent device
합성예 에서 합성된 화합물 A-9 ~ 73, B-13 ~ 20, C-9 ~ 29, D-17 ~ 23, E-17 ~ 23, G-17 ~ 29, I-2 ~ 13, J-2 ~ 17, K-1 ~ 9를 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 하기와 같이 청색 유기 전계 발광 소자를 제작하였다.Compounds synthesized in Synthesis Example A-9 to 73, B-13 to 20, C-9 to 29, D-17 to 23, E-17 to 23, G-17 to 29, I-2 to 13, J- After high-purity sublimation purification of 2 to 17 and K-1 to 9 by a commonly known method, a blue organic electroluminescent device was manufactured as follows.
먼저, ITO (Indium tin oxide)가 1500 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음 UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.First, ITO (Indium tin oxide) is 1500 The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. The substrate was transferred to a vacuum evaporator.
상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (㈜두산전자, 80 nm)/NPB (15 nm)/ADN + 5 % DS-405 (㈜두산전자, 30nm)/화합물 A-9 ~ 73, B-13 ~ 20, C-9 ~ 29, D-17 ~ 23, E-17 ~ 23, G-17 ~ 29, I-2 ~ 13, J-2 ~ 17, K-1 ~ 9각각의 화합물 (30 nm)/LiF (1 nm)/Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제작하였다. On the ITO transparent electrode prepared as above, DS-205 (Doosan Electronics, 80 nm)/NPB (15 nm)/ADN + 5 % DS-405 (Doosan Electronics, 30 nm)/Compounds A-9 to 73, B -13 ~ 20, C-9 ~ 29, D-17 ~ 23, E-17 ~ 23, G-17 ~ 29, I-2 ~ 13, J-2 ~ 17, K-1 ~ 9 each compound ( 30 nm)/LiF (1 nm)/Al (200 nm) were stacked in the order to fabricate an organic electroluminescent device.
[비교예 2] 청색 유기 전계 발광 소자의 제작[Comparative Example 2] Fabrication of a blue organic electroluminescent device
전자 수송층 물질로서 화합물 A-9 대신 Alq3을 사용하는 것을 제외하고는, 상기 실시예 40과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 40, except that Alq3 was used instead of Compound A-9 as the electron transport layer material.
[비교예 3] 청색 유기 전계 발광 소자의 제작[Comparative Example 3] Fabrication of a blue organic electroluminescent device
전자 수송층 물질로서 화합물 A-9을 사용하지 않은 것을 제외하고는, 상기 실시예 40과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다.A blue organic electroluminescent device was manufactured in the same manner as in Example 40, except that Compound A-9 was not used as the electron transport layer material.
상기 실시예 40 내지 142 및 비교예 2, 3에서 사용된 NPB, AND 및 Alq3의 구조는 하기와 같다. The structures of NPB, AND, and Alq3 used in Examples 40 to 142 and Comparative Examples 2 and 3 are as follows.
[평가예 2][Evaluation Example 2]
실시예 40 내지 142 및 비교예 2, 3에서 제작한 각각의 청색 유기 전계 발광 소자에 대하여 전류밀도 (10) mA/㎠에서의 구동전압, 전류효율 및 발광 피크를 측정하고, 그 결과를 하기 표 2에 나타내었다.For each of the blue organic electroluminescent devices manufactured in Examples 40 to 142 and Comparative Examples 2 and 3, the driving voltage, current efficiency and emission peak at a current density (10) mA/cm 2 were measured, and the results are shown in the table below 2 is shown.
(V)drive voltage
(V)
(nm)EL peak
(nm)
(cd/A)current efficiency
(cd/A)
상기 표 2에 나타낸 바와 같이, 본 발명의 화합물을 전자 수송층에 사용한 청색 유기 전계 발광 소자(실시예 40 내지 142)는 종래의 Alq3를 전자 수송층에 사용한 청색 유기 전계 발광 소자(비교예 2) 및 전자 수송층이 없는 청색 유기 전계 발광 소자(비교예 3)에 비해 구동전압, 발광피크 및 전류효율 면에서 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 2, the blue organic electroluminescent device (Examples 40 to 142) using the compound of the present invention for the electron transport layer was a blue organic electroluminescent device using the conventional Alq3 for the electron transport layer (Comparative Example 2) and electron It was found that the blue organic EL device without a transport layer (Comparative Example 3) exhibited superior performance in terms of driving voltage, emission peak and current efficiency.
[실시예 143~168] 청색 유기 전계 발광 소자의 제조 [Examples 143 to 168] Preparation of blue organic electroluminescent device
합성예 A-1~8, C-1~4, E-1~4, F-1~4, G-5~8에서 합성된 화합물을 통상적으로 알려진 방법으로 고순도 승화정제를 한 후, 아래의 과정에 따라 청색 유기 전계 발광 소자를 제작하였다.After high-purity sublimation purification of the compound synthesized in Synthesis Examples A-1~8, C-1~4, E-1~4, F-1~4, G-5~8 by a conventionally known method, According to the process, a blue organic electroluminescent device was manufactured.
ITO (Indium tin oxide)가 1500 두께로 박막 코팅된 유리 기판을 증류수 초음파로 세척하였다. 증류수 세척이 끝나면, 이소프로필 알코올, 아세톤, 메탄올 등의 용제로 초음파 세척을 하고 건조시킨 후, UV OZONE 세정기(Power sonic 405, 화신테크)로 이송시킨 다음, UV를 이용하여 상기 기판을 5분간 세정하고 진공 증착기로 기판을 이송하였다.ITO (Indium tin oxide) is 1500 The thin film-coated glass substrate was washed with distilled water and ultrasonic waves. After washing with distilled water, ultrasonic cleaning with a solvent such as isopropyl alcohol, acetone, methanol, etc. and transferred the substrate to a vacuum evaporator.
상기와 같이 준비된 ITO 투명 전극 위에, DS-205 (80 nm) / NPB (15 nm) / ADN + 5 % DS-405 (㈜두산전자, 30nm) / A-1~8, C-1~4, E-1~4, F-1~4, G-5~8 (5 nm) / Alq3 (25 nm) / LiF (1 nm) / Al (200 nm) 순으로 적층하여 유기 전계 발광 소자를 제조하였다.On the ITO transparent electrode prepared as above, DS-205 (80 nm) / NPB (15 nm) / ADN + 5 % DS-405 (Doosan Electronics, 30 nm) / A-1~8, C-1~4, E-1~4, F-1~4, G-5~8 (5 nm) / Alq3 (25 nm) / LiF (1 nm) / Al (200 nm) were stacked in the order to prepare an organic electroluminescent device. .
이때 사용된 NPB, ADN 및 Alq3의 구조는 다음과 같다.The structures of NPB, ADN and Alq3 used at this time are as follows.
[비교예 4] 청색 유기 전계 발광 소자의 제조[Comparative Example 4] Preparation of blue organic electroluminescent device
실시예 143에서 전자수송보조층 물질로 사용된 화합물 A-1을 사용하지 않고, 전자 수송층 물질인 Alq3를 25 nm 대신 30 nm로 증착하는 것을 제외하고는, 실시예 143과 동일하게 수행하여 청색 유기 전계 발광 소자를 제작하였다. In Example 143, the same procedure as in Example 143 was performed, except that Compound A-1 used as an electron transport auxiliary layer material was not used, and Alq3, an electron transport layer material, was deposited at 30 nm instead of 25 nm. An electroluminescent device was fabricated.
[평가예 3][Evaluation Example 3]
실시예 143 내지 168 및 비교예 4에서 각각 제조된 유기 전계 발광 소자에 대하여, 전류밀도 10 mA/㎠에서의 구동전압, 발광파장, 전류효율, 발광파장을 측정하였고, 그 결과를 하기 표 3에 나타내었다.For the organic electroluminescent devices prepared in Examples 143 to 168 and Comparative Example 4, respectively, the driving voltage, emission wavelength, current efficiency, and emission wavelength at a current density of 10 mA/cm 2 were measured, and the results are shown in Table 3 below. indicated.
(V)drive voltage
(V)
(nm)luminescence peak
(nm)
표 3에 나타낸 바와 같이, 본 발명에 따른 화합물로 형성된 전자수송보조층을 포함하는 실시예 143 ~ 168의 청색 유기 전계 발광 소자는 전자수송보조층 없이 Alq3로 된 전자수송층을 포함하는 비교예 4의 유기 전계 발광 소자에 비해 전류 효율 및 구동전압 면에서 우수한 성능을 나타내는 것을 알 수 있었다.As shown in Table 3, the blue organic electroluminescent device of Examples 143 to 168 including an electron transport auxiliary layer formed of the compound according to the present invention is Comparative Example 4 comprising an electron transport layer made of Alq3 without an electron transport auxiliary layer It was found that the organic electroluminescent device exhibited superior performance in terms of current efficiency and driving voltage.
10: 양극 20: 음극
30: 유기층 31: 정공 수송층
32: 발광층 33: 정공 수송 보조층
34: 전자 수송층 35: 전자 수송 보조층
36: 전자 주입층 37: 정공 주입층10: positive electrode 20: negative electrode
30: organic layer 31: hole transport layer
32: light emitting layer 33: hole transport auxiliary layer
34: electron transport layer 35: electron transport auxiliary layer
36: electron injection layer 37: hole injection layer
Claims (11)
[화학식 1]
상기 화학식 1에서,
L은 단일결합이거나, 또는 C6~C18의 아릴렌기 및 핵원자수 5 내지 18개의 헤테로아릴렌기로 이루어진 군에서 선택되며,
n 은 0 내지 3의 정수이며,
상기 A 및 B는 각각 독립적으로 하기 화학식 2 내지 화학식 4 중 어느 하나로 표시되는 치환기이며,
[화학식 2]
[화학식 3]
[화학식 4]
상기 화학식 2 내지 화학식 4에서,
*는 결합이 이루어지는 부분이고,
복수의 X는 서로 동일하거나 상이하고, 각각 독립적으로 C(R) 또는 N이나, A로 표시되는 화학식 2 및 화학식 3에 의한 X는 적어도 둘 이상이 N이며,
R은 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고, 서로 인접하는 기와 지방족, 방향족, 지방족헤테로 또는 방향족헤테로의 축합 고리를 형성하거나 스피로 결합을 이룰 수 있고,
상기 R의 알킬기, 알케닐기, 알키닐기, 아릴기, 헤테로아릴기, 아릴옥시기, 알킬옥시기, 시클로알킬기, 헤테로시클로알킬기, 아릴아민기, 알킬실릴기, 알킬보론기, 아릴보론기, 아릴포스핀기, 모노 또는 디아릴포스피닐기 및 아릴실릴기는 각각 독립적으로 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C6~C60의 아릴옥시기, C1~C40의 알킬옥시기, C6~C60의 아릴아민기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C1~C40의 알킬실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴실릴기로 이루어진 군에서 선택된 1종 이상의 치환기로 치환되거나 비치환되고, 복수 개의 치환기로 치환되는 경우, 이들은 서로 동일하거나 상이할 수 있으며,
m 은 1 내지 3의 정수이며,
Ar1이 복수인 경우, 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 알킬이거나, 치환 또는 비치환된 알케닐기이거나, 치환 또는 비치환된 알키닐기이거나, 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이며, 인접한 X와 축합 고리를 형성할 수 있으며,
Ar2 및 Ar3은 서로 동일하거나 상이하고, 각각 독립적으로 치환 또는 비치환된 아릴기이거나, 치환 또는 비치환된 헤테로아릴기이다.A compound represented by the following formula (1):
[Formula 1]
In Formula 1,
L is a single bond, or is selected from the group consisting of a C 6 ~ C 18 arylene group and a heteroarylene group having 5 to 18 nuclear atoms,
n is an integer from 0 to 3,
A and B are each independently a substituent represented by any one of the following Chemical Formulas 2 to 4,
[Formula 2]
[Formula 3]
[Formula 4]
In Formulas 2 to 4,
* is the part where the bond is made,
A plurality of Xs are the same or different from each other, and each independently C (R) or N, but X represented by Formula 2 and Formula 3 represented by A is at least two or more N,
R is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ mono or diaryl phosphine of C 60 blood group and a C 6 ~ C is selected from the 60 group consisting of aryl amines, form a condensed ring of the group aliphatic, aromatic, aliphatic hetero, or aromatic heterocyclic group which are adjacent to each other, or to achieve a spiro bond there is,
R of an alkyl group, an alkenyl group, an alkynyl group, an aryl group, a heteroaryl group, an aryloxy group, an alkyloxy group, a cycloalkyl group, a heterocycloalkyl group, an arylamine group, an alkylsilyl group, an alkylboron group, an arylboron group, an aryl group Phosphine group, mono or diarylphosphinyl group and arylsilyl group are each independently deuterium, halogen, cyano group, nitro group, C 1 ~ C 40 alkyl group, C 2 ~ C 40 alkenyl group, C 2 ~ C 40 alkynyl group, C 6 ~ C 60 aryl group, heteroaryl group having 5 to 60 nuclear atoms, C 6 ~ C 60 aryloxy group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryl Amine group, C 3 ~ C 40 cycloalkyl group, heterocycloalkyl group having 3 to 40 nuclear atoms, C 1 ~ C 40 alkylsilyl group, C 1 ~ C 40 alkylboron group, C 6 ~ C 60 aryl boron group, C 6 ~ C substituted with at least 60 of the aryl phosphine group, C 6 ~ C 60 mono or diaryl phosphine blood group and a C 6 ~ selected from the group consisting arylsilyl of C 60 one kind of substituent or being unsubstituted , when substituted with a plurality of substituents, they may be the same or different from each other,
m is an integer from 1 to 3,
When Ar1 is plural, it is the same or different from each other, and each independently is a substituted or unsubstituted alkyl, a substituted or unsubstituted alkenyl group, a substituted or unsubstituted alkynyl group, a substituted or unsubstituted aryl group, It is a substituted or unsubstituted heteroaryl group, and may form a condensed ring with adjacent X,
Ar2 and Ar3 are the same as or different from each other, and each independently represents a substituted or unsubstituted aryl group, or a substituted or unsubstituted heteroaryl group.
상기 화학식 2는 화학식5 내지 화학식 10으로 이루어진 군으로부터 선택되는 것을 특징으로 하는 화합물:
[화학식 5]
[화학식 6]
[화학식 7]
[화학식 8]
[화학식 9]
[화학식10]
상기 화학식 5 내지 화학식 10에서,
*는 결합이 이루어지는 부분이고,
Y는 수소, 중수소, 할로겐, 시아노기, 니트로기, C1~C40의 알킬기, C2~C40의 알케닐기, C2~C40의 알키닐기, C3~C40의 시클로알킬기, 핵원자수 3 내지 40개의 헤테로시클로알킬기, C6~C60의 아릴기, 핵원자수 5 내지 60개의 헤테로아릴기, C1~C40의 알킬옥시기, C6~C60의 아릴옥시기, C3~C40의 알킬실릴기, C6~C60의 아릴실릴기, C1~C40의 알킬보론기, C6~C60의 아릴보론기, C6~C60의 아릴포스핀기, C6~C60의 모노 또는 디아릴포스피닐기 및 C6~C60의 아릴아민기로 이루어진 군에서 선택되고,
X 및 Ar1은 각각 청구항 1에서 정의된 바와 같다.According to claim 1,
Formula 2 is a compound, characterized in that selected from the group consisting of Formulas 5 to 10:
[Formula 5]
[Formula 6]
[Formula 7]
[Formula 8]
[Formula 9]
[Formula 10]
In Formulas 5 to 10,
* is the part where the bond is made,
Y is hydrogen, deuterium, halogen, cyano group, nitro group, C1~ C40 alkyl group, C2~ C4 0 alkenyl group, C 2 ~ C 40 alkynyl group, C 3 ~ C 40 cycloalkyl group, 3 nuclear atoms to 40 heterocycloalkyl group, C 6 ~ C 60 aryl group, 5 to 60 nuclear atoms heteroaryl group, C 1 ~ C 40 alkyloxy group, C 6 ~ C 60 aryloxy group, C 3 ~ C 40 Alkylsilyl group, C 6 ~ C 60 Arylsilyl group, C 1 ~ C 40 Alkyl boron group, C 6 ~ C 60 Aryl boron group, C 6 ~ C 60 Arylphosphine group, C 6 ~ of C 60 mono or diaryl phosphine group P is selected from the group consisting of C 6 ~ C 60 aryl amine,
X and Ar1 are each as defined in claim 1.
상기 화학식 3은 화학식 11인 것을 특징으로 하는 화합물:
[화학식 12]
상기 화학식 11에서,
*는 결합이 이루어지는 부분이고,
X는 청구항 1에서 정의된 바와 같다.According to claim 1,
Formula 3 is a compound characterized in that the formula 11:
[Formula 12]
In the above formula (11),
* is the part where the bond is made,
X is as defined in claim 1.
상기 화학식 4은 화학식 12 또는 화학식 13인 것을 특징으로 하는 화합물:
[화학식 12]
[화학식 13]
상기 화학식 12 내지 화학식 13에서,
*는 결합이 이루어지는 부분이고,
X는 청구항 1에서 정의된 바와 같다.According to claim 1,
Formula 4 is a compound characterized in that it is Formula 12 or Formula 13:
[Formula 12]
[Formula 13]
In the above formulas 12 to 13,
* is the part where the bond is made,
X is as defined in claim 1.
상기 화학식 5는 하기 화학식 14 또는 화학식 15인 것을 특징으로 하는 화합물:
[화학식 14]
[화학식 15]
상기 화학식 14 또는 화학식 15에서,
*는 결합이 이루어지는 부분이고,
Ar1은 청구항 1에서 정의된 바와 같다.3. The method of claim 2,
Formula 5 is a compound characterized in that it is represented by Formula 14 or Formula 15:
[Formula 14]
[Formula 15]
In Formula 14 or Formula 15,
* is the part where the bond is made,
Ar1 is as defined in claim 1.
상기 화학식 6은 하기 화학식 16인 것을 특징으로 하는 화합물:
[화학식 16]
상기 화학식 16에서,
*는 결합이 이루어지는 부분이고,
Ar1은 청구항 1에서 정의된 바와 같다.3. The method of claim 2,
Formula 6 is a compound characterized in that the following formula 16:
[Formula 16]
In the formula (16),
* is the part where the bond is made,
Ar1 is as defined in claim 1.
상기 화학식 4는 하기 화학식 17인 것을 특징으로 하는 화합물:
[화학식 17]
상기 화학식 17에서,
*는 결합이 이루어지는 부분이다.3. The method of claim 2,
Formula 4 is a compound characterized in that the following formula 17:
[Formula 17]
In Formula 17,
* is the part where the connection is made.
L은 단일결합이거나, 하기 L-1 내지 L-3 중에서 선택되는 링커인 것을 특징으로 하는 화합물:
L-1 내지 L-3에서,
*는 결합이 이루어지는 부분이다.According to claim 1,
L is a single bond or a compound characterized in that it is a linker selected from the following L-1 to L-3:
In L-1 to L-3,
* is the part where the connection is made.
상기 화합물은 아래의 화합물로 이루어진 군에서 선택되는 것을 특징으로 하는 화합물:
According to claim 1,
The compound is a compound characterized in that it is selected from the group consisting of:
상기 1층 이상의 유기물층 중에서 적어도 하나는 제1항의 화학식 1로 표시되는 화합물을 포함하는 것을 특징으로 하는 유기 전계 발광 소자.An organic electroluminescent device comprising (i) an anode, (ii) a cathode, and (iii) one or more organic material layers interposed between the anode and the cathode,
At least one of the one or more organic material layers is an organic electroluminescent device comprising the compound represented by the formula (1) of claim 1.
상기 유기물층은 정공 주입층, 정공 수송층, 정공 수송 보조층, 전자 수송층, 전자 수송 보조층 및 발광층으로 이루어진 군에서 선택되는 하나 이상의 층을 포함하는, 유기 전계 발광 소자.11. The method of claim 10,
The organic material layer is an organic electroluminescent device comprising one or more layers selected from the group consisting of a hole injection layer, a hole transport layer, a hole transport auxiliary layer, an electron transport layer, an electron transport auxiliary layer, and a light emitting layer.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200074329A KR20210156587A (en) | 2020-06-18 | 2020-06-18 | Organic light-emitting compound and organic electroluminescent device using the same |
PCT/KR2021/007630 WO2021256880A1 (en) | 2020-06-18 | 2021-06-17 | Organic light-emitting compound and organic electroluminescent device using same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020200074329A KR20210156587A (en) | 2020-06-18 | 2020-06-18 | Organic light-emitting compound and organic electroluminescent device using the same |
Publications (1)
Publication Number | Publication Date |
---|---|
KR20210156587A true KR20210156587A (en) | 2021-12-27 |
Family
ID=79177311
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020200074329A KR20210156587A (en) | 2020-06-18 | 2020-06-18 | Organic light-emitting compound and organic electroluminescent device using the same |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20210156587A (en) |
WO (1) | WO2021256880A1 (en) |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150033082A (en) | 2013-09-23 | 2015-04-01 | 에스케이케미칼주식회사 | Compound for organic electroluminescent device and organic electroluminescent device comprising the same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2015169412A1 (en) * | 2014-05-05 | 2015-11-12 | Merck Patent Gmbh | Materials for organic light emitting devices |
US10297762B2 (en) * | 2014-07-09 | 2019-05-21 | Universal Display Corporation | Organic electroluminescent materials and devices |
JP6629291B2 (en) * | 2014-07-21 | 2020-01-15 | メルク、パテント、ゲゼルシャフト、ミット、ベシュレンクテル、ハフツングMerck Patent GmbH | Materials for electronic devices |
KR101694487B1 (en) * | 2014-10-24 | 2017-01-11 | (주)위델소재 | Quinoxaline derivative compound, pyridopyrazine derivative compound and organic electroluminescent devices using the sames |
KR102199112B1 (en) * | 2018-07-31 | 2021-01-06 | 솔루스첨단소재 주식회사 | Organic compound and organic electroluminescent device using the same |
-
2020
- 2020-06-18 KR KR1020200074329A patent/KR20210156587A/en not_active Application Discontinuation
-
2021
- 2021-06-17 WO PCT/KR2021/007630 patent/WO2021256880A1/en active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20150033082A (en) | 2013-09-23 | 2015-04-01 | 에스케이케미칼주식회사 | Compound for organic electroluminescent device and organic electroluminescent device comprising the same |
Also Published As
Publication number | Publication date |
---|---|
WO2021256880A1 (en) | 2021-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6703223B2 (en) | Organic compound and organic electroluminescent device including the same | |
KR102463379B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR102499850B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20210075535A (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20210156913A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20160085603A (en) | Organic electro luminescence device | |
KR102643057B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR101571597B1 (en) | Organic compound and organic electroluminescent device comprising the same | |
KR102617952B1 (en) | Organic light-emitting compound and organic electroluminescent device comprising the same | |
KR102248650B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20170065291A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20220008636A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR102587384B1 (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20230047988A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20200142220A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR102083923B1 (en) | Organic electro luminescence device | |
KR102307342B1 (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR20190030391A (en) | Organic compounds and organic electro luminescence device comprising the same | |
KR20210156587A (en) | Organic light-emitting compound and organic electroluminescent device using the same | |
KR102507368B1 (en) | Organic compound and organic electroluminescent device using the same | |
KR20200107339A (en) | Organic compound and organic electroluminescent device comprising the same | |
KR20200119647A (en) | Organic compound and organic electroluminescent device comprising the same | |
KR102384652B1 (en) | Organic compound and organic electro luminescence device comprising the same | |
KR102530093B1 (en) | Organic light-emitting compound and organic electroluminescent device comprising the same | |
KR102013982B1 (en) | Organic compound and organic electroluminescent device comprising the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E902 | Notification of reason for refusal |